NOTICE

COMBINED ORDINARY AND

EXTRAORDINARY

GENERAL SHAREHOLDERS' MEETING

On 26 May 2020 at 10:30 a.m

(First notice)

Auditorium

10, boulevard de Grenelle

75015 Paris

Eramet - Combined Shareholders' Meeting of 26 May 2020

2

Eramet - Combined Shareholders' Meeting of 26 May 2020

TABLE OF CONTENTS

Agenda of the Combined Ordinary and Extraordinary General Shareholders' Meeting

4

  • Summary of the operations of the Eramet Group during the year 2019 - Extract from the Press

Release of 19 February 2020

5

Extract from the Press Release of 30 March 2020

15

Explanatory Statement

18

Text of Draft Resolutions

19

Composition of the Board of Directors as of February, 19 2020

27

  • « Say On Pay Ex Ante » :
    Approval of the remuneration policy of the management and administration bodies,

following Article L. 225-37-2 of the French Commercial Code

38

  • « Say On Pay Ex Post » :
    Approval of the information referred to in paragraph I of Article L.225-37-3 of the French

Commercial Code - Fixed, variable and exceptional elements that make up the total remuneration and benefits of any kind granted to the Chairman and CEO for the year ended

50

How to attend or vote at the Shareholders' Meeting ?

65

Request Form for documents and information

69

* * *

3

Eramet - Combined Shareholders' Meeting of 26 May 2020

AGENDA OF THE COMBINED ORDINARY AND EXTRAORDINARY

GENERAL SHAREHOLDERS' MEETING

Under the authority of the Ordinary Shareholders' Meeting

  • Report from the Board of Directors on the 2019 financial year.
  • Report from the Board of Directors on corporate governance.
  • Report from the Statutory Auditors on the annual accounts.
  • Report from the Statutory Auditors on the consolidated financial statements.

• Approval of the financial statements (annual and consolidated) for the year ended December 31, 2019.

  • Special report from the statutory auditors on the agreements considered in Articles L 225-38 and seq. of the French Commercial Code.
  • Approval of the agreements covered by this report and submitted to the shareholders' vote.
  • Allocation of result for the 2019 financial year.
  • Renewal of mandates of Directors.
  • « Say on Pay Ex Ante » - Approval of the remuneration policy applicable to the members of the Board of Directors.
  • « Say on Pay Ex Ante » - Approval of the remuneration policy applicable to Ms Christel Bories, CEO.
  • « Say on Pay Ex Post » - Approval of the provisions mentioned in paragraph I of Article L. 225-37-3 of the French Commercial Code.
  • « Say on Pay Ex Post » - Approval of the fixed, variable and exceptional elements comprising the total remuneration and benefits of any kind paid for the year ended to Ms Christel Bories, Chairman and CEO.
  • Authorization to trade in the Company's shares

Under the authority of the Extraordinary Shareholders' Meeting

  • Amendment to article 11 of the Articles of Association.
  • Amendment to Article 13 of the Articles of Association.
  • Amendment to Article 10.8 of the Articles of Association.
  • Amendment to Article 10.9 of the Articles of Association.
  • Amendment to Article 21 of the Articles of Association.
  • Amendment to Article 22 of the Articles of Association.

Under the authority of the Ordinary Shareholders' Meeting

  • Powers.

4

Eramet - Combined Shareholders' Meeting of 26 May 2020

SUMMARY OF THE OPERATIONS

OF THE ERAMET GROUP DURING THE YEAR 2019

Extract from the Press Release of 19 February 2020

Eramet's Board of Directors met on 19 February 2020, under the chairwomanship of Christel BORIES, and approved the financial statements for the 2019 financial year(1) which will be submitted for approval at the General Shareholders' meeting on 26 May 2020.

(1): Audit procedures for the 2019 consolidated financial statements are complete. The certification report will be issued after the Board of Directors' meeting held on 12 March 2020, which will set the draft shareholders' resolutions

  • Safety

The total recordable injury rate (FR26) declined considerably again in 2019, from 8.3 to 5.4, down 35%, thanks to increased commitment and vigilance shown from all employees. However, the Group was very saddened to report the deaths of four people during the course of the year, of which one employee of a subcontractor. Safety of each and every one with a zero-tolerance policy for severe accidents remains the first priority for the Group.

Eramet Group key figures

(Millions d'euros)1

2019

20182

Change

Change3

(€m)

(%)

Sales

3 671

3 825

(154)

- 4 %

EBITDA

630

843

(213)

- 25 %

Current operating income (COI)

341

581

(240)

- 41 %

Net income, Group share

(184)

53

(237)

n.a.

Free Cash-Flow

(358)

(211)

(147)

- 70 %

Net debt (net cash), excl. IFRS 16 impact

1 207

717

490

+ 68 %

Gearing4, excl. IFRS 16 impact

74 %

38 %

+ 36 pts

n.a.

Gearing4, incl. IFRS 16 impact

80 %

38 %

+ 42 pts

n.a.

ROCE (COI/capital employed5 for previous year)

12 %

22 %

- 10 pts

n.a.

  1. Data rounded up to the nearest million. 2019 figures after application of IFRS 16 on 1st January 2019, except for net debt and gearing. The comparative table is presented in Appendix 7, not significant impact on EBITDA and COI
  2. Until 2018, data adjusted from Group reporting in which joint ventures are accounted for using proportional consolidation. The reconciliation with the published financial statements is presented in Appendix6
  3. Data rounded up to higher or lower %
  4. Net debt-to-equity ratio
  5. Total shareholders' equity, net debt, restoration provisions, restructuring and other social risks, less long-term investments, excluding Weda Bay Nickel capital employed
  6. FR2 = number of lost time and recordable injury accidents for 1 million hours worked (employees and subcontractors

N.B.: all the commented changes in FY 2019 are calculated with respect to FY 2018, unless otherwise specified.

5

Eramet - Combined Shareholders' Meeting of 26 May 2020

The Group's FY 2019 sales totalled €3,671m, down 4%. At constant scope7,8 and exchange rates8, the change in sales declined 8%, mainly owing to the decline in manganese ore prices, in addition to the supply chain situation at Aubert & Duval, due to bringing quality processes into conformity.

Group EBITDA ended at €630m, down -€213m, impacted by a -€268m manganese price effect and -€49m due to supply chain difficulties at Aubert & Duval. Operating improvements (+€39m) were also penalised by the strikes in H2 2018 and H1 2019 at SLN, which affected ore supplies and operations at the Doniambo plant, as well as by an increase in transport costs at Comilog. These effects hindered the operational breakthroughs made in 2019, specifically production records in the mines.

The Group's current operating income ended at €341m, down 41%.

Income before tax amounted to €89m, after recognition of -€118m in non-operatingincome and expenses, including a provision for an asset impairment at Erasteel (-€25m), and -€134m in financial result.

Net income, Group share reported a loss of -€184m, after writing down a -€227m tax charge. This charge is largely owing to taxes in Gabon (-€147m).

Capex has been focused on modernising industrial tools and preparing strategic projects. Related cash outflow totalled €423m, of which €132m in preparation work for the two strategic projects in Gabon and Argentina.

Free Cash-Flow(FCF) ended at -€358m at end-December 2019, of which -€274m in non-recurringitems. This includes the -€160mnon-recurring effect related to supply chain difficulties at Aubert & Duval, of which -€80m due to the strong increase in work-in-progress inventories. FCF was also penalised by a - €114m payment made to the Gabonese government related, on the one hand, to the advance and exceptional payment of corporate income tax, and on the other, to the payment of a tax audit.

Finally, dividends paid to Eramet shareholders and Comilog minority shareholders in respect of the 2018 financial year amounted to €20m and €86m respectively.

Net debt stood at €1,207m, excluding the IFRS 16 impact. Eramet has applied IFRS 16 since 1st January 2019 with a simplified retrospective application, resulting in an increase of €97m, with no impact on cash, and total recorded net debt of €1,304m.

  • Financial strategy

In 2019, the Group set up a Term Loan, with a 2-year maturity and an option that can be exercised by Eramet to extend it to January 2024. The financing amounts to €350m, thanks to participation from eight French and international banks. It's the first time two of these banks are working with Eramet.

At 31 December 2019, Eramet's financial liquidity remained high at €2.3bn, including available cash of €848m in the balance sheet.

The evolution in the Group's financial ratios (gearing at 74% excluding IFRS impact and gearing at 63%9 within the meaning of the financial covenants) drove management to start an action plan.

  1. The scope effect is owing to i) the full consolidation of Mineral Sands activity in the Group's reporting as of 1st July 2018, following 7 The scope effect is owing to i) the full consolidation of Mineral Sands activity in the Group's reporting as of 1st July 2018, following the acquisition of shares in Mineral Deposits Limited, an Australian company that held a 50% stake in TiZir. and ii) the consolidation by equity method of UKAD (High Performance Alloys division) as of 1st January 2019.
  2. See Financial glossary in Appendix 8
  3. Excl. IFRS 16 impact and excl. French government loan to SLN

6

Eramet - Combined Shareholders' Meeting of 26 May 2020

The Group took measures to maintain cash position, including strict industrial capex control, with the aim of controlling the level of net debt and preserving gearing. The Group might also plan initiatives to strengthen its financial structure such as disposals or partnerships.

Moreover, a proposal not to pay out any dividends in respect of the 2019 financial year will be made at the Shareholders' general meeting held on 26 May 2020.

  • Key figures by activity

2019

20182

Change

Change3

(Millions of euros)1

(€m)

(%)

MINING AND METALS DIVISION

Manganese BU

Sales

1 765

1 857

(92)

- 5 %

EBITDA

560

784

(224)

- 29 %

Nickel BU

Sales

778

738

40

+ 5 %

EBITDA

38

(18)

56

n.a.

Mineral Sands BU4

Sales

286

212

74

+ 35 %

EBITDA

106

62

44

+70 %

HIGH PERFORMANCE ALLOYS DIVISION

A&D and Erasteel

Sales

847

1 020

(173)

- 17 %

EBITDA

(26)

46

(72)

n.a.

1 Data rounded up to the nearest million. 2019 figures after IFRS 16 application on 1st January 2019. The comparative table is presented in Appendix 7

  1. Until 2018, data adjusted from Group reporting in which joint ventures are accounted for using proportional consolidation. The reconciliation with the published financial statements is presented in Appendix 6
  2. Data rounded up to higher or lower %
  3. Mineral Sands activity fully consolidated in the Group's accounts as of 1st July 2018, versus 50% previously
  • Mining and Metals Division

Manganese BU

The Manganese BU's sales, which accounts for 48% of the Group's consolidated sales, fell by 5% to €1,765m in 2019, compared with 2018. Despite significant increases in ore production levels (+10%), ore and alloys market prices declined considerably, particularly at year-end, generating EBITDA at €560m, down 29%.

Market trends & prices

Global production for carbon steel, the main end-market for manganese, reached a record level of 1,86710 Mt in 2019, up 3.6%10, despite a slowdown in H2. This growth was almost exclusively driven by strong demand in China (+8.3%10 at 996 Mt, representing 53% of global production) supported by the construction and infrastructure markets. Production was down across the rest of the world (-1.3%10), most notably with a sharp decline in the European market (-5.1%10), whereas the Indian market trended upwards (+1.8%10).

10. Eramet estimations based on World Steel Association ("WSA") production data available for 2019 excluding data regarding inventories levels at Chinese ports (Eramet estimations)

7

Eramet - Combined Shareholders' Meeting of 26 May 2020

In order to respond to growing ore consumption, and considering that manganese ore prices were kept at high levels for the first nine months of the year, all producers continued to operate at full capacity. This resulted in a slightly surplus supply/demand balance over the 2019 financial year. As a result, ore inventories in Chinese ports amounted to 4.7 Mt10 at end-2019, up 1.6 Mt10 versus end-2018.

CIF China 44% manganese ore market prices trended very negatively in Q4 (-34%11 vs. average for first 9 months of the year) resulting in an average price of $5.63/dmtu11 in 2019, down 21% on 2018 ($7.16/dmtu11). In euros, the decrease only amounted to 17% over the year, given the appreciation of the dollar.

In 2019, the market environment also remained unfavourable for manganese alloys, which were adversely impacted by a slowdown in Europe, linked on the one hand to the sudden decline in the automotive market and on the other to protectionist measures taken by the United States, which are weighing on European steel production. Manganese alloys' prices fell in Europe, particularly for refined ferromanganese (-7%11) and silico-manganese(-5%11).

Activities

In Gabon, Comilog set a new record for ore production at 4.8 Mt (+10%), greatly exceeding the target of

4.5 Mt set for 2019. This excellent performance reflects continued operational improvements in mines, complying with CSR standards. It was achieved thanks to the new dry ore processing process started end- 2018, which extracted approximately 0.5 Mt of ore during the year.

Thanks to logistics improvements, produced and transported manganese ore volumes increased by 17%, to

4.6 Mt. The renovation programme for the Transgabonese railway has shown signs of success. Global freight volume (mining and others) increased 22% in 2019 from 2018 (+70% since the programme started end-2016), benefitting all Gabonese economic stakeholders. 2019 marked a key milestone with the establishment of the new traffic control centre equipped with digital communication resources with mobile trains. A total of €166m in capex has been made as part of the programme since its launch in 2016, with €19m paid for by the Gabonese government.

Thus, external ore sales grew 15% to 3.9 Mt over the same period.

Manganese alloys production totalled 740 kt in 2019 (+3%). Sales volumes were up 4% to 733 kt, propelled by standard alloys (+16%), with a decrease in refined ferromanganese alloys (-8%) due to a sharp downturn in the market. This unfavourable mix in addition to the margin squeeze for manganese alloys - particularly due to the downward momentum in sales prices - adversely affected performance in this activity.

Outlook

The growth outlook for global carbon steel production remains favourable in the short and medium term.

Mine reserves in Moanda, Gabon, allow a manganese ore production capacity of approximately 7 Mt in the long-term. In 2019, Eramet thus continued its brownfield expansion study for the mine aimed at the development of the Okouma plateau, in parallel with the Bangombé plateau currently in operation. Cash outflow for preparation work in 2019 totalled €51m. The target set for manganese ore production in 2020 is more than 5 Mt.

The expansion project was reviewed based on a new modular approach. This approach optimises capex and is based on the start of production at the Okouma plateau and on the intensified use of the alternative dry processing for the entire mine. This process gives greater flexibility in mining operations and extends the mine life.

11. Change calculated based on average monthly prices: CRU index (manganese ore and alloys)

8

Eramet - Combined Shareholders' Meeting of 26 May 2020

Looking ahead, the modular approach shows an initial production improvement phase of around 25% on 2019, representing approximately 6 Mt. This phase will account for overall capex estimated at €150m over a 2-year period. The schedule for roll-out is being finalised with our partner, the Gabonese government.

Nickel BU

The Nickel BU's sales increased 5%, ending at €778m in 2019 with EBITDA of €38m. SLN12 EBITDA stood at €59m, up 74% from 2018. In a favourable price environment, SLN recorded the initial effects of its rescue plan, despite operating performance that was strongly impacted by a decline in ferronickel production due to disruptions and strikes in the mines. At the same time, the Sandouville plant's operating loss was halved, with EBITDA of -€21m.

Market trends & prices

The 2019 financial year was marked by continued trade tensions between the United States and China, as well as the September announcement in Indonesia to ban exports of nickel ore that has not been transformed locally, effective 1st January 2020. This measure is aimed at profoundly affecting market equilibrium for the various players.

After slightly increasing in H1 (+2.1%13 vs. H1 2018), global stainless steel production grew considerably in H2, reaching a record level of 51.7 Mt in 2019, up 4.2%13. Production in China increased from 12.2%13 to 29.6 Mt and slowed in the rest of the world (-4.8%13). Indonesia continued to present a unique situation with stainless steel production up 4,7%13, due to the start of locally integrated production upstream from NPI ("Nickel Pig Iron" 14).

Demand for primary nickel was up 3.6%13 over the period to 2.4 Mt, boosted by both stainless steel and the development of electric vehicle batteries, which grew by 30%13 in 2019 (to 176 kt of primary nickel).

In parallel, global primary nickel production was up significantly (+8.9%13) to 2.3 Mt at end-2019, driven by continued growth in NPI ("Nickel Pig Iron"14) production in Indonesia and China (+30%13), whereas traditional production was down slightly.

Considering a nickel supply/demand balance with a high deficit in 2018 (- 141 kt13), this production increase was nevertheless not enough to satisfy the change in demand, resulting in a further deficit of more than 31 kt13 in 2019. Nickel stocks at the LME15 and SHFE15 continued to fall, amounting to 191 kt at end- December 2019 (-31 kt vs. end-December 2018, i.e. -14%), equivalent to slightly more than 7 weeks of consumption (including nickel producers' inventories), the lowest level since end-2006.

The average LME price was $6.31/lb in 2019, representing an increase of 6% from 2018 (average of $5.95/lb), largely owing to the early September announcement that the Indonesian ban was being reintroduced16. The average H2 price ended at $7.03/lb, up 26% from H1 ($5.59/lb). The increase in LME prices in euros was +12% on an annual basis, factoring in the appreciation of the dollar.

Parallel to this, the price of nickel seaborne ore (1.8% CIF China) also rose sharply in H2 compared with H1. The average price went from $50.68/wmt17 to $66.58/wmt17, an increase of +31%.

Activities

In New Caledonia, after a difficult first-half, impacted by strikes in one of the main mining centres, the second half of 2019 was marked by the continued implementation of the SLN rescue plan, whose effects were achieved in part.

  1. SLN, ENI and others
  2. Eramet estimations
  3. Low-gradenickel ferroalloys
  4. LME: London Metal Exchange; SHFE: Shanghai Futures Exchange
  5. Ban on the export of nickel ore produced in Indonesia as of 1st January 2020
  6. CNFEOL: China Ferroalloy Online

9

Eramet - Combined Shareholders' Meeting of 26 May 2020

In 2019, despite large-scale strikes in the first half, nickel ore production was up 15%, achieving a record18 of 4.7 Mwmt19. This was attributable to the new mine schedule working times applied since mid-May on all mining centres. The volume of low-grade ore exported exceeded the target set, ending at 1.6 Mwmt19(+32%). The new mine schedule working times in addition to further discussions with local inhabitants should confirm the target of reaching the 4 Mwmt export rate of ore in 2021.

Given the blockade of mining centres on the East coast, supply to the ore smelting furnaces at the Doniambo plant remained disrupted for the entire year, with a 13% (47 kt) decrease in ferronickel production in 2019. Ferronickel sales volumes also fell by 15% to 47 kt over the same period.

Despite the implementation of new organisations at the mine and plant, the considerable decrease in ferronickel volumes weighed on SLN's cash-cost, which ended at $5.91/lb in 2019. Cash-cost substantially improved in H2, at $5.74/lb ($6.05/lb in H1), particularly due to export volumes and the increase in the market price of ore following the announcement of the Indonesian ban.

On this basis, SLN generated cash in H2 2019, specifically in the fourth quarter.

In November, the Group achieved a third milestone20 in the implementation of the rescue plan by signing an agreement with Enercal, SLN's electricity provider. Through this agreement, Eramet achieves a third21 of the required target to reduce energy prices. Other options are still being discussed with local partners in order to identify additional initiatives that will be key to achieving the overall objective of SLN's rescue plan.

The intrinsic reduction cash-cost target of $1.30/lb22on a full-year basis in 2021 remains dependent on the plan being rolled out without disruptions, especially with regard to social and societal aspects.

Moreover, digital transformation, specifically connected mines, should improve productivity. It is also a lever for performance improvement at SLN.

In addition, SLN's newly-established business model significantly increases the company's mining reserves and resources, particularly following the integration of lower grade tonnages for exports. SLN's

mineral

resources

increased

approximately

fourfold

(~4),

amounting

to

19.4 Mt of contained nickel, with an average grade of more than 1.85%. This makes SLN one of the world's leading mining operators.

At the Sandouville plant in Normandy, progress continued thanks to technical corrections implemented by an expert task force and strengthened site management. Nickel salt and high-purity nickel metal production roughly doubled (~2), versus 2018. This resulted in the plant doubling its sales to €90m. The loss was halved and cash consumption significantly reduced, with FCF of -€32m in 2019 (vs. -€54m). Factoring in the progress made in 2019, 2020 EBITDA should be close to break-even.

Outlook

At Weda Bay, Indonesia, as part of a partnership with Tsingshan, mining works started end-2019, with 900 employees currently working at one of the largest nickel deposits in the world. This mine will provide ore for several NPI14 plants situated on the island of Halmahera. The target for nickel ore production is 6 Mwmt in the long-run, with more than 3 Mwmt as early as of 2020. To allow the start-up of calcination and smelting operations at the JV plant with Tsingshan at Weda Bay, more than 0.5 Mwmt19 of nickel ore inventory was built up at end-2019.

  1. Over a 5-year period
  2. Mwmt: millions of wet metric tonnes; kth: thousands of wet metric tonnes
  3. After being granted a 10-year authorisation by the local government to export 4 Mth a year of low-grade nickel ore and signing new agreements on working times in mines and plant
  4. This proposal represents an initial step in lowering energy prices as of 1st January 2020, leading to a flat-rate reduction of €8.5m per year, subject to conditions, assuming that the price of nickel is below $6.5/lb. Conversely, if the price of nickel on the international markets exceeded $10.0/lb, SLN has committed to return part of its profits for a maximum flat-rate amount of €8.5m per year.
  5. At end-2018,kick-start of the rescue plan

10

Eramet - Combined Shareholders' Meeting of 26 May 2020

At the same time, construction of this plant is in its latter stages. Production at the plant should start in H1 2020, ahead of the initial schedule. However, the Coronavirus epidemic could affect the activity's launch schedule.

The ramp-up in the plant's production is expected to be fast, with 80% of nominal capacity by end-2020, thereby benefitting from a favourable NPI environment thanks to the introduction of the Indonesian ban. The plant is expected to be well positioned as far as production costs are concerned with a cash-cost consistent with the best Indonesian producers.

Mineral Sands BU

This activity now contributes approximately 17% of the Group's EBITDA, demonstrating the success of the Group's strategy in mineral sands. TiZir's sales grew 5% to €286m in 2019 (at comparable scope, full basis). EBITDA was up considerably by 32% at €106m, thanks to good operating performance and favourable prices.

Market trends & prices

Global demand for zircon decreased by 10% on 2018, largely due to a decline in the ceramics market (~50% of end-products for zircon). The other application areas (mainly chemicals and refractory materials markets) were stable overall during the year, with a year-end downturn for refractory materials. Zircon supply remained strong, generating a surplus zircon supply/demand balance for 2019.

Compared with levels at end-2018, prices gradually lowered in 2019, albeit maintaining a high level. On an average annual basis, premium zircon market prices rose to $1,575/t23, up 7% on 2018. Factoring in the currency effect, the price increase in euros was +13%.

Global demand for TiO2 pigments (~90% of end-products for titanium-based products) remained stable in 2019. Demand for high value-added raw materials producers bolstered demand in CP grade titanium slag as produced in Norway. The average price of CP grade titanium slag thus increased by 10% to $752/t 24 compared with 2018. Factoring in the currency effect, the price increase in euros was +16%.

Activities

Upstream, in Senegal, thanks to further improvements (+6%) in operating performance25, annual production for heavy mineral concentrates26 at the Grande Côte (GCO) site reached 735 kt, exceeding the target set. The decline in production (-5% vs. 2018) is an expected reflection of the lowest grade (-11% on average in 2019 vs. 2018) for the deposit area currently in operation following the mining plan.

Zircon sales volumes were down 11% in 2019 at 58 kt. H2 offset part of the decline of the start of the year (- 16% in H1).

Downstream, in TiZir's Norwegian plant, titanium slag production remained stable at 189 kt, penalised by a metal casting incident, which resulted in a production shutdown for 4 weeks. Sales volumes decreased by 10% to 180 kt since the 2018 financial year benefitted from destocking effects.

Outlook

With the medium-term in mind, the Group is reviewing options to debottleneck mineral sand production in Senegal, with a focus on organic growth for GCO production. Initial results for this study should be available in H2 2020. The aim is to optimise the use of available capacity in ore beneficiation plant as well as in transport, leading to step-by-step increases in production.

  1. Source Zircon premium:FerroAlloyNet.com, Eramet analysis
  2. Source: Market consulting, Eramet analysis
  3. OEE: Overall Equipment Efficiency reflects the intensity of mining production (real production / maximum theoretical production)
  4. Titanium-relatedore (ilmenite, rutile and leucoxene) and zircon

11

Eramet - Combined Shareholders' Meeting of 26 May 2020

Furthermore, following a global international tender procedure, Eramet secured exploration permits on the rutile block of Akonolinga, in Cameroon. The three-year long permits will allow the Eramet teams to conduct the necessary fieldwork and feasibility studies. This long-term project, which is fully in line with Eramet's exploration strategy, would provide a diversification of the Group product portfolio on the particularly attractive rutile market.

BU Lithium (Project)

In 2019, Eramet continued development works for its lithium deposit in Argentina, with an annual production target of 24 kt in LCE (Lithium Carbonate Equivalent). Capex for preparation work ended at €81m for the year, including the pilot plant on site. This pilot is currently operating in real conditions, confirming an excellent yield level to date, leading to a first quartile cash-cost position, amongst the most competitive in the industry.

The project is currently on hold and expenses have been reduced to a minimum, since required conditions for launch have not yet been met. This specifically applies to the Argentinian regulations' context and to the economic environment.

  • High Performance Alloys division

The High Performance Alloys division's sales were down 17% to €847m and EBITDA showed a loss of -€26m. This underperformance results from delivery delays at Aubert & Duval, in turn caused by bringing its quality process into conformity, and particularly deteriorated market conditions for Erasteel's activity.

Market trends

In the aerospace sector, which accounts for more than 70% of Aubert & Duval's sales, the market

environment remains stable. Through a diversified product portfolio that covers medium and long-haul

aircraft, the company was little affected by Boeing's situation in 2019. The reduced Boeing 737 MAX

production rates and the announced Airbus A380 production shutdown were offset by record deliveries for the Airbus A320 aircraft and maintained production output for long-haul planes at Boeing.

Moreover, Aubert & Duval recently signed contracts with leading players in the aerospace and energy sector, paving the way to medium-term growth outlook and market share gains for the single-aisle programmes, landing gears and gas turbines segments.

Erasteel's markets (high-speed steels) were adversely affected by the sharp slowdown in the automotive sector in Europe and China in 2019, which is expected to continue in the coming months. The company was also penalised by the increase in customs duties, which are heavily impacting the exports of high quality high-speed steels to the United States.

Activities

At Aubert & Duval27, sales declined considerably by 19% to €642m28, with EBITDA at break-even (vs. +€36m in 2018). Bringing quality processes into conformity continues with all customers concerned, and continued to weigh on deliveries, significantly impacting Aubert & Duval's sales and performance. The momentum of the corrective action plan launched end-2018 enabled all sites to return to a normal billing rate since September, with the exception of Les Ancizes site, which nevertheless came close to a normal rate at year-end. In Q4, Aubert & Duval's monthly billing rate came out 15% above the monthly average for the year, reflecting a general trend reversal in delays observed since September.

Delays in deliveries for the closed die-forged parts BU continue to decrease and a return to normal inventory levels is expected in 2020. Delays in Forged and Rolled Products BUs still remain significant,

  1. Aubert & Duval, EHA and others
  2. Excl. UKAD sales, accounted for using the equity method as of 1st January 2019 (2018 UKAD sales: €44m)

12

Eramet - Combined Shareholders' Meeting of 26 May 2020

especially at Les Ancizes site. A specific action plan has been rolled out in order to increase capabilities for the final production and control phases.

Throughout the year, combined expertise and background work have been conducted, working closely with customers. All this work will continue in 2020. This expertise has resulted in in-depth restructuring of former production and management routines. This key structural initiative will extend throughout 2020. An additional accrual of €15m was booked in 2019 to take into account the estimated cost to date of processing this in-depth review of quality processes (especially expertise costs). Total costs are estimated to be €80 m.

To date, Aubert & Duval has not been subject to any judicial developments as part of bringing its quality processes into conformity.

The ramifications of the logistics difficulties have adversely affected Aubert & Duval's performance in 2019: -€49m impact on EBITDA, -€160m impact on FCF, including an increase in work-in-progress inventory levels (€80 m).

At Erasteel, sales were down 10% at €205m in a strongly declining market. EBITDA recorded a loss of - €27m (vs. +€10m in 2018), also significantly penalised by the decline in raw material prices in recent months, particularly for cobalt and vanadium. Despite highly unfavourable market conditions, FCF showed marked improvement near break-even at -€3m. This was particularly due to well managed WCR and specifically stocks.

Factoring in Erasteel's current market outlook, an asset impairment charge of €25m has been booked as other non-current income and expenses at end-2019.

Outlook

Following a strategic review conducted in 2018 and actions to bring quality processes to conformity, the High Performance Alloys Division has launched a long-termin-depth restructuring programme. Several corrective actions are included:

  • restructuring organisations and reshaping former managerial routines,
  • reviewing portfolio of subsidiaries and focusing activities and capex on six key segments,
  • improving operating performance, particularly in safety, product quality control, customer service and equipment reliability.

The Group will continue to roll out these initiatives in 2020 to ensure a sustainable recovery in this division's performance.

  • CSR roadmap

Eramet has a long-standing commitment to a responsible approach and continuous improvement. The Group makes Corporate Social Responsibility the key focus of its activities. In 2018, the Group set out its CSR roadmap, which connects key challenges affecting our society and the environment to Eramet's strategic vision. This 2018-2023 CSR roadmap is based on three core components: acting as a committed player to women and men, a responsible economic player and a committed player to our planet. For each of the thirteen objectives that make up the roadmap, Eramet has set out quantitative and qualitative targets.

In order to assess overall progress in its Roadmap, Eramet measures its CSR performance index, which is based on yearly achievements. For the 2019 financial year, this index came out at 112, i.e. 12 points above the targets set for the year (the index measures overall average progress within the roadmap). Most of the objectives established for the year were achieved. More than half of them exceeded the agreed milestones.

This particularly applied to three of the environmental objectives, focused on rehabilitation of mining sites, dust emissions and industrial waste valorisation.

13

Eramet - Combined Shareholders' Meeting of 26 May 2020

Eramet's growth strategy across all its subsidiaries is based on a sustainable and contributive foothold in its host countries, which is built in a spirit of partnership with all of its stakeholders. Eramet, a committed corporate citizen, is developing its projects in line with the highest international standards regarding the environment, society and ethics.

14

Eramet - Combined Shareholders' Meeting of 26 May 2020

Extract from the Press Release of 30 March 2020

Eramet : fully committed to face the Covid-19 health situation

In the current context of the Coronavirus pandemic marked by the uncertainty in the global economy, Eramet is fully committed to tackling developments in the situation.

The Group has two priorities:

  • Protecting the health of all its employees as well as their family, and contributing to containing the pandemic, while complying with all health safety measures imposed by relevant authorities
  • Ensuring, to the extent possible, business continuity by adapting organisations, working closely with employees, suppliers and customers.

A crisis meeting is held on a daily basis to coordinate actions in all the Group's locations. A health protocol compliant with authorities' recommendations is being rolled out across all sites.

Considering the uncertainty surrounding the length of the pandemic as well as its scale and impact on the Group's supplies and markets, Eramet is currently not in a position to accurately measure its impact on production and performance targets for 2020. As a result, the Group decided to suspend guidance for 2020 production and EBITDA as communicated to the market in its press release of 19 February 2020. Once there is more visibility on the impact of the pandemic, Eramet will provide an update on its outlook for the current financial year.

The Group's liquidity level - €2.3bn at 31 December 2019, which includes lines of liquidity that had not been drawn down at that date for €1.5bn - remains high. All credit lines have since been drawn down as a precaution. Cash preservation measures have also been strengthened and accelerated in order to preserve Group liquidity and financing capacity; main levers include cost and capital expenditures cutting to a strict minimum, as well as new measures put in place to closely control invoicing flows and cash collection processes.

As regards the Mining and Metals division, in a fast-changing environment, it is still too soon to assess the pandemic's overall impact in the quarters ahead. There is still considerable uncertainty about how the pandemic will affect the outlook for end-markets, notably the carbon steel and the stainless steel industries and the entire value chain. Some countries, including South Africa and India, have temporarily suspended their mining and metallurgy activities. Parallel to this, business activity is gradually resuming in China, the main global consumer of manganese, nickel and raw materials overall. Nonetheless, Chinese producers have built up large carbon and stainless steel inventories that are likely to weigh on demand for raw materials eventually. In Europe, steel industry players have announced a number of slowdowns and temporary suspensions in production, especially impacting products in the automotive sector.

Mining and metallurgy production have not been significantly impacted to date (Gabon, New Caledonia, Senegal, mainland France, Norway and the United States). However, the situation could change rapidly. First-quarter order intakes are still at a normal level, particularly in Asia, which accounts for more than half of the division's sales. As it stands, the division's mines and metallurgical plants are in a position to provide the volume ordered.

In Indonesia, as announced end-February, the low-grade nickel ferroalloy (NPI) plant that the Group is developing in a joint venture should start operations in first-half 2020.

Moreover, manganese ore market prices1 observed since early 2020 are above those of fourth-quarter 2019 on average. Conversely, nickel prices at the LME are down approximately 17% on average since the start of the year versus fourth-quarter 2019.

Regarding the High Performance Alloys division, as a result of the health protocol being rolled out across all sites, the division is currently reorganising its plants' production lines to ensure continuity in its industrial operations. This adaptation results in a temporary shutdown or suspension for some activities in

1 Eramet estimations

15

Eramet - Combined Shareholders' Meeting of 26 May 2020

France. With half of its activity driven by the aerospace sector, the division expects to start operations again gradually in line with the rebound in business for large accounts in the sector.

Moreover, the Group has set up a systematic teleworking system for service functions.

16

Eramet - Combined Shareholders' Meeting of 26 May 2020

EXPLANATORY STATEMENT

Dear Shareholders,

Please find below an explanatory note regarding the resolutions proposed for voting at your Combined General Meeting.

Resolutions 1 and 2 concern the approval of the parent company financial statements and the consolidated financial statements for the past financial year. The detailed financial statements can be found in the documents distributed to shareholders and are commented upon in the management report:

In resolution 3, you are asked to approve the special report of the Statutory Auditors of your Company pertaining to the agreements specified in Articles L. 225-38 et seq. of the French Commercial Code and authorised during the past financial year. You are asked to note that the report also presents the agreements previously authorised by your Meeting, which continued in the prior year and that, as these previously authorised agreements have already been approved by your Meeting, they are not being put to a vote by this Meeting.

The purpose of Resolution 4 is to propose to the Shareholders' Meeting the appropriation of income for the 2019 financial year.

Resolutions 5 to 6 concern the renewal for four years of the terms of office of directors expiring at this Shareholders' Meeting:

  • Renewal of the term of office of Ms Miriam Maes (independent director). Ms Maes has held executive management positions in several international companies and is sitting on the Boards of directors of several companies.
  • Renewal of the term of office of Ms Sonia Sikorav (independent director). Ms Sikorav has held executive management, strategy management and procurement management positions in different industrial groups.

Pursuant to the provisions of Article L. 225-37-2 paragraph II and Article R. 225-29-1 of the French Commercial Code, the General Shareholders' Meeting is called to approve resolution 7 of the remuneration policy applicable to the members of the Board of Directors (paragraphs 7.1.2.2 and 7.1.1.3) and resolution 8 the remuneration policy applicable to Ms Christel Bories, Chief Executive Officer. These disclosures are provided in Chapter 7 (paragraph 7.1 and more particularly 7.1.2.1) of the 2019 Universal Registration Document, "Remuneration of the management and administration bodies".

In accordance with the wording of Article L. 225-37-2, the approval of the General Shareholders' Meeting is required every year and upon each material change to the remuneration policy. If the General Shareholders' Meeting does not approve the resolution and if it has previously approved a compensation policy, the latter shall continue to apply and the Board of Directors shall submit a draft resolution presenting a revised remuneration policy to the next General Shareholders' Meeting for approval. In the absence of a previously approved compensation policy, if the General Shareholders' Meeting does not approve the draft resolution, remuneration shall be determined in accordance with the remuneration assigned in the previous year, or, in the absence of remuneration assigned in the previous year, in accordance with existing practices within the Company.

Pursuant to the provisions of Article L. 225-37-3 paragraph I of the French Commercial Code, the General Shareholders' Meeting is called in resolution 9, to approve the information mentioned in Article L.225-37- 3 paragraph I of the French Commercial Code. These disclosures are provided in Chapter 7 (paragraphs

7.2.1 and 7.2.2) of the 2019 Universal Registration Document, "Remuneration of the management and administration bodies". Pursuant to the provisions of Article L. 225-100 paragraph III of the French Commercial Code, the General Shareholders' Meeting is called in resolution 10, to approve the fixed, variable and exceptional components of the remuneration and benefits of any kind, paid in the past financial year or assigned in the same financial year to Ms Christel Bories, Chief Executive Officer in respect of the 2019 financial year. These disclosures are provided in Chapter 7 (paragraph 7.2.3) of the

2019 Universal Registration Document, "Remuneration of the management and administration bodies".

17

Eramet - Combined Shareholders' Meeting of 26 May 2020

The purpose of Resolution 11, in the context of the provisions of Article L. 225-209 of the French Commercial Code, is to request authorisation from the General Shareholders' Meeting to renew, in accordance with applicable laws and regulations, the Company's share buyback programme, using any and all means, including during a public offering. The maximum buyback amount is 10% of the capital and the maximum purchase price per share is EUR 200. This resolution concerns the annual renewal of this authorisation. The main purpose of this authorisation is to allow the existing liquidity agreement to continue, and the employee bonus share plans to be implemented through the award of existing shares.

Resolution 12 concerns the amendment of Article 3 of the Articles of Association and is proposed in order to incorporate the possibility to appoint a lead director.

Resolution 13 concerning the amendment to Article 13 of the Articles of Association is proposed in order to incorporate the new provisions on the broader social interest in taking into consideration the social and environmental issues of the activity set out in Article L. 225-35sub-par. 1 of the French Commercial Code (from Pacte law 2019-486 of 22 May 2019).

Resolution 14 concerning the amendment of Article 10.8 of the Articles of Association is proposed in order to integrate the new provisions of Article L. 225-45 of the French Commercial Code (resulting from Pacte Law 2019-486 of 22 May 2019): the notion of directors' fees is replaced by the notion of directors' compensation.

Resolution 15 concerning the amendment of Article 10.9 of the Articles of Association is proposed in order to integrate the new provisions of Article L. 225-27-1 of the French Commercial Code (resulting from Pacte Law 2019-486 of 22 May 2019): the threshold for appointing a second director representing employees has been lowered from twelve to eight members. This article does not in any way amend the current composition of the Eramet Board of Directors, which currently has a total of more than eight members.

Furthermore, as Eramet had set up a Social and Economic Council in Spring 2019 instead of a Works Council, Article 10.9 of the Articles of Association is also amended accordingly.

Resolutions 16 and 17 concern the amendments of Article 21 and Article 22 of the Articles of Association and are proposed for the purpose of incorporating the new provisions of Articles L. 225-96 and L. 225-98 of the French Commercial Code (resulting from Act 2019-744 of 19 July 2019 (known as the "simplification, clarification and update of company law" Act): now Ordinary and Extraordinary General Shareholders' Meetings vote by majority of votes cast.

Resolution 18 allows the formalities involved in implementing the other resolutions voted by the combined

General Shareholders' Meeting to be fulfilled.

The Board of Directors

18

Eramet - Combined Shareholders' Meeting of 26 May 2020

TEXT OF DRAFT RESOLUTIONS

UNDER THE AUTHORITY OF THE ORDINARY GENERAL

SHAREHOLDERS' MEETING

FIRST RESOLUTION

(2019 annual financial statements)

The Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, after hearing read aloud the Board of Directors' report and the Statutory Auditors' report on the annual financial statements for the financial year ended 31 December 2019, approves said annual financial statements as presented to it, and the transactions translated in these financial statements or summarised in these reports.

SECOND RESOLUTION

(2019 consolidated financial statements)

The Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, after hearing read aloud the Board of Directors' report and the Statutory Auditors' report on the consolidated financial statements for the financial year ended 31 December 2019, approves the said consolidated financial statements as presented to it, and the transactions translated in these financial statements or summarised in these reports.

THIRD RESOLUTION

(Regulated agreements)

The General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, after hearing read aloud the special report drawn up by the Statutory Auditors on the agreements specified in Articles L.225-38 et seq. of the French Commercial Code, approves this report and the transactions set out therein.

FOURTH RESOLUTION(Appropriation of income)

The General Shareholders' Meeting, acting with the quorum required for Ordinary Shareholders' Meetings,

Notes that the income for the financial year ended is .............................

EUR 4,697,098.88

In addition to retained earnings

at 31 December 2019 ..............................................................................

EUR 287,893,778.27

I.e. a distributable amount of .................................................................

EUR 292 590 877.15

The General Shareholders' Meeting resolves:

To allocate to the legal reserve the amount required to raise it to its maximum of 10% of the share capital, i.e. ................................................................................................................ EUR 35.38

To allocate the balance to retained earnings which will then amount to EUR 292,590,841.77

The General Shareholders' Meeting, in its Ordinary session, duly notes that the dividends per share to be paid for the past year and the three previous years are, or were, as follows:

2016

2017

2018

2019

Number of shares

26,550,443

26,633,660

26,635,884

26,636,000

compensated

dividend

EUR 0

EUR 2.30

EUR 0.60

EUR 0

19

Eramet - Combined Shareholders' Meeting of 26 May 2020

FIFTH RESOLUTION

(Renewal of a director's term of office)

The General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, renews for a period of four years, i.e., until the General Shareholders' Meeting held in 2024, called to approve the financial statements for the 2023 financial year, the term of office of Ms Miriam Maes, which expires at this meeting.

SIXTH RESOLUTION

(Renewal of a director's term of office)

The General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, renews for a period of four years, i.e., until the General Shareholders' Meeting held in 2024, called to approve the financial statements for the 2023 financial year, the term of office of Ms Sonia Sikorav, which expires at this meeting.

SEVENTH RESOLUTION(Approval of the remuneration policy applicable to the members of the Board of Directors - "Say on Pay Ex Ante" -)

Pursuant to the provisions of Article L. 225-37-2 paragraph II and of Article R. 225-29-1 of the French Commercial Code, the General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, approves the remuneration policy applicable to the members of the Board of Directors, as presented in the company's corporate governance report described in Article L. 225-37 of the French Commercial Code and in the 2019 Universal Registration Document, Section 7 "Remuneration of the management and administration bodies", paragraphs 7.1.1.3 and 7.1.2.2.

EIGHTH RESOLUTION(Approval of the remuneration policy applicable to Ms Christel Bories, Chief Executive Officer - "Say on Pay Ex Ante" -)

Pursuant to the provisions of Article L. 225-37-2 paragraph II and of Article R. 225-29-1 of the French Commercial Code, the General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, approves the remuneration policy applicable to Ms Christel Bories, Chief Executive Officer, as presented in the company's corporate governance report described in Article L. 225-37 of the French Commercial Code and in the 2019 Universal Registration Document, Section 7 "Remuneration of the management and administration bodies", paragraph 7.1 and more particularly 7.1.2.1.

NINTH RESOLUTION(Approval of the information mentioned in Article L. 225-37-3 paragraph I of the French Commercial Code - "Say on Pay Ex Post")

Pursuant to the provisions of Article L. 225-37-3 paragraph I and of Article L. 225-100 paragraph II of the French Commercial Code, the General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, approves the information mentioned in paragraph I of Article L. 225-37-3 of the French Commercial Code as presented in the company's corporate governance report described in the last sub-paragraph of Article L. 225-37 of the French Commercial Code appearing in the 2019 Universal Registration Document, Section 7 "Remuneration of the management and administration bodies", paragraphs 7.2.1 and 7.2.2.

TENTH RESOLUTION(Approval of the fixed, variable and exceptional components of the total remuneration and the benefits of any kind paid or assigned in respect of the 2019 financial year to Ms Christel Bories, Chief Executive Officer - "Say on Pay Ex Post ")

Pursuant to the provisions of Article L. 225-100 paragraph III of the French Commercial Code, the General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, approves the fixed, variable and exceptional components of the total remuneration and benefits of any kind paid or assigned in respect of the 2019 financial year to Ms Christel Bories, Chief Executive Officer, as presented in the company's corporate governance report described in Article L. 225-37 of the French Commercial Code appearing in the 2019 Universal Registration Document, Section 7 "Remuneration of the management and administration bodies", paragraph 7.2.3.

20

Eramet - Combined Shareholders' Meeting of 26 May 2020

ELEVENTH RESOLUTION

(Authorisation to act on the Company's shares)

The General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, after acknowledging the Board of Directors' report and the description of the Company's share buyback programme, using the option provided by Article L. 225-209 of the French Commercial Code, authorises the Board of Directors to purchase or arrange for the purchase of the Company's shares within the limit of 10% of the share capital, with a view to:

  • supporting the share price via a liquidity agreement with a market maker, in accordance with the market practice accepted by the AMF;
  • the delivery of shares upon the exercise of rights attached to securities giving access to the share capital by redemption, conversion, exchange or otherwise;
  • the implementation of any stock option plan of the Company pursuant to the provisions of articles L.225-177 et seq. of the French Commercial Code;
  • the allocation of bonus shares under the provisions of articles L. 225-197-1 et seq. of the French Commercial Code;
  • the allocation or the transfer of shares to the employees with respect to their participation in the benefits of the expansion of the company, or the implementation of any employee savings plan under the conditions stipulated by the law, in particular, the articles L.3332-1 et seq. of the French Labour Code;
  • their cancellation, in accordance with the 26th resolution of this General Shareholders' Meeting of 23 May 2019, authorising the reduction of the Company's share capital for a period of 26 months.

These shares may be purchased, disposed, transferred or exchanged by any and all means, on the market or over the counter, including as applicable, through derivatives and the maximum share may be acquired or transferred in the form of share blocks, which may comprise the entirety of the authorised share buyback.

They may also be made during a period of public offering if the purchase offer for the Company's securities is fully settled in cash.

The payment may be made as follows.

The maximum purchase price shall not exceed EUR 200 per share.

This authorisation is given for a period ending with the General Shareholders' Meeting called to approve the financial statements for 2020.

On the basis of the number of shares comprising the share capital at 31 December 2019, the maximum theoretical investment shall, assuming a share price of EUR 200, amount to EUR 532,720,000.

In order to ensure this resolution is executed, all powers are granted to the Board of Directors, which may delegate them for the purpose of:

  • executing all stock exchange orders, entering into all agreements concerning in particular, keeping share purchase and sale registers,
  • making all declarations to the French financial markets authority,
    assigning or reassigning the shares acquired to the different objectives pursued in accordance with the applicable laws and regulations,
  • fulfilling all other formalities and, generally, doing whatever is needed.

21

Eramet - Combined Shareholders' Meeting of 26 May 2020

UNDER THE AUTHORITY OF THE EXTRAORDINARY SHAREHOLDERS' MEETING

TWELFTH RESOLUTION

(Amendment of Article 11 of the Articles of Association)

The General Shareholders' Meeting, acting with the quorum and majority required for Extraordinary Shareholders' Meetings, after reviewing the Board of Directors' resolves to amend Article 11 of the Articles of Association in order to adopt the following text.

Present version

New version

Article 11 - Offices of the Board of directors

Article 11 - Offices of the Board of directors

1. The Board may decide to create committees.

1. The Board may decide to create committees.

2. On the proposal of the Chairman, the Board may

2. On the proposal of the Chairman, the Board may

decide to appoint two Vice Chairmen from among its

decide to appoint two Vice Chairmen from among its

members.

members.

If the Chairman is unable to preside over the Board,

If the Chairman is unable to preside over the Board,

one of the Vice-Chairmen shall preside over the Board

one of the Vice-Chairmen shall preside over the Board

of Directors and the General Meetings of

of Directors and the General Meetings of

Shareholders.

Shareholders.

3. The Board may furthermore appoint, for the

3. The Board may furthermore appoint, for the

duration that it sees fit, a Secretary, who is not

duration that it sees fit, a Secretary, who is not

required to be chosen from among the Board members.

required to be chosen from among the Board members.

4. The Board shall draw up a charter to which each

4. The Board shall draw up a charter to which each

Director or permanent representative shall subscribe

Director or permanent representative shall subscribe

upon taking office and that recalls or defines the

upon taking office and that recalls or defines the

mission of the Directors, the principles that govern

mission of the Directors, the principles that govern

their action and the rules of conduct that they establish

their action and the rules of conduct that they establish

for themselves in that respect.

for themselves in that respect.

5. The Board may decide to appoint a lead director

whose missions are defined by the Board in

accordance with the Afep-Medef code of gouvernance.

THIRTEENTH RESOLUTION

(Amendment of Article 13 of the Articles of Association)

The General Shareholders' Meeting, acting with the quorum and majority required for Extraordinary Shareholders' Meetings, after reviewing the Board of Directors' report and the provisions of Article L.225- 35 of the French Civil Code resulting from law 2019-486 of 22 May 2019 (known as the "Pacte law") resolves to amend Article 13 of the Articles of Association to adopt the following text.

Present version

New version

Article 13 - Powers of the Board of Directors

Article 13 - Powers of the Board of Directors

The Board of Directors determines the orientations of

The Board of Directors determines the orientations of

the Company's activity and ensures that they are

the Company's activity and ensures that they are

implemented.

implemented by taking into consideration the social

and environmental issues of its activity.

Subject to the powers expressly assigned to

Subject to the powers expressly assigned to

Shareholders' Meetings and within the limit of the

Shareholders' Meetings and within the limit of the

corporate purpose, it reviews any issue pertaining to

corporate purpose, it reviews any issue pertaining to

the smooth operation of the company and through its

the smooth operation of the company and through its

deliberations settles any business within its purview.

deliberations settles any business within its purview.

22

Eramet - Combined Shareholders' Meeting of 26 May 2020

No resolution regarding the strategic, economic,

No resolution regarding the strategic, economic,

financial or technological orientations of the company

financial or technological orientations of the company

may be passed without the prior deliberation of the

may be passed without the prior deliberation of the

Board.

Board.

The resolutions of the Board of Directors limiting the

The resolutions of the Board of Directors limiting the

powers of general management are not binding on third

powers of general management are not binding on

parties. Securities, endorsements and guarantees on

third parties. Securities, endorsements and guarantees

company assets must be authorised by the Board of

on company assets must be authorised by the Board of

Directors under conditions set out by law.

Directors under conditions set out by law.

Acts concerning the Company are signed either by the

Acts concerning the Company are signed either by the

Chief Executive Officer, the Deputy Chief Executive

Chief Executive Officer, the Deputy Chief Executive

Officer or by any person specially authorised to do so.

Officer or by any person specially authorised to do so.

FOURTEENTH RESOLUTION

(Amendment of Article 10.8 of the Articles of Association)

The General Shareholders' Meeting, acting with the quorum and majority required for Extraordinary Shareholders' Meetings, after reviewing the Board of Directors' report and the provisions of Article L.225- 45 of the French Civil Code resulting from law 2019-486 of 22 May 2019 (known as the "Pacte law") resolves to amend Article 10.8 of the Articles of Association in order to adopt the following text.

Present version

New version

8. The General Shareholders' Meeting may allocate to 8. The General Shareholders' Meeting may allocate an

the Directors an annual fixed sum in directors' fees.

annual fixed sum to Directors as compensation for

their activity.

The Board of Directors shall allocate these fees among

The Board of Directors shall allocate these fees among

its members in the manner it sees fit.

its members in the manner it sees fit.

The Board may allocate exceptional compensation for

The Board may allocate exceptional compensation for

missions or mandates entrusted to Directors.

missions or mandates entrusted to Directors.

FIFTEENTH RESOLUTION

(Amendment of Article 10.9 of the Articles of Association)

The General Shareholders' Meeting, acting with the quorum and majority required for Extraordinary Shareholders' Meetings, after reviewing the Board of Directors' report and the provisions of Article L.2312-75 of the French Labour Code and Article L.225-27-1 of the French Commercial code resulting from law 2019-486 of 22 May 2019 (known as the "Pacte law") resolves to amend Article 10.9 of the Articles of Association in order to adopt the following text.

Present version

New version

9. Apart from the directors whose number and method

9. Apart from the directors whose number and method

of appointment are set out in Articles L.225-17 and

of appointment are set out in Articles L.225-17 and

L.225-18 of the French Commercial Code, when the

L.225-18 of the French Commercial Code, when the

Company meets the criteria set in Article L. 225-27-1

Company meets the criteria set in Article L. 225-27-1

paragraph I of the French Commercial Code, the Board

paragraph I of the French Commercial Code, the Board

of Directors, as required by Article L. 225-27-1 of the

of Directors, as required by Article L. 225-27-1 of the

French Commercial Code, shall include directors

French Commercial Code, shall include directors

representing employees.

representing employees.

Two directors shall be appointed to represent

Two directors shall be appointed to represent

employees when the number of directors mentioned in

employees when the number of directors mentioned in

Articles L. 225-17 and L. 225-18 of the French

Articles L. 225-17 and L. 225-18 of the French

Commercial Code exceeds twelve and one director

Commercial Code is more than eightand one director

shall be appointed to represent employees when there

shall be appointed to represent employees when there

are twelve or fewer directors.

are eightor fewer directors.

23

Eramet - Combined Shareholders' Meeting of 26 May 2020

Directors representing employees are appointed as follows:

  1. where two directors are to be appointed, one of the directors is appointed by the central works council as specified in Articles L. 2327-1 et seq. of the French Labour Code, and the other director is appointed by the European works council.
  2. where a single director is to be appointed, he or she is appointed by the central works council as specified in Articles L. 2327-1 et seq. of the French Labour Code.

If the number of directors mentioned in Articles L.225-

17 and L.225-18 of the French Commercial Code, after being less than or equal to twelve, becomes more than twelve, the Chair of the Board of Directors shall, within a reasonable period, consult the European works council in order to appoint a second director to represent employees.

If the number of directors mentioned in Articles L. 225-17 and L. 225-18 of the French Commercial Code, after exceeding twelve, were to fall to twelve or less, the term of office of the director representing employees appointed by the European works council will continue until its term, but shall not be renewed if the number of directors remains less than or equal to twelve as at the renewal date.

Article 10.7 of these Articles of Association are not applicable to directors representing employees. Directors representing employees are not taken into account to determine the maximum number of directors set out in Article 10.1 of these Articles of Association.

The term of office of directors representing employees is four years from the date of their appointment. Newly appointed directors representing employees take up office at the expiry of the term of office of the outgoing directors representing employees.

The term of office of the directors representing employees shall legally end in the event of termination of their employment contract with the Company or one of its direct or indirect subsidiaries, dismissal in accordance with Article L. 225-32 of the French Commercial Code, or if an event of incompatibility arises as stated in Article L. 225-30 of the French Commercial Code.

In the event that during his or her term of office, for any reason whatsoever (such as death, resignation, dismissal, termination of employment contract), a the seat of a director representing employees becomes vacant, it shall be filled using the same appointment procedures as those described in the third sub-section of this Article 10.9. The term of office of the director thus appointed shall end at the completion of the normal term of office of his or her predecessor. Until the date on which the director representing employees is replaced, the Board of Directors may meet and

Directors representing employees are appointed as follows:

  1. where two directors are to be appointed, one of the directors is appointed by the social and economic councilas specified in Articles L. 2311-1 et seq. of the French Labour Code, and the other director is appointed by the European works council.
  2. where a single director is to be appointed, he or she is appointed by the social and economic workcouncil as specified in Articles L. 2311-1 et seq. of the French Labour Code.

If the number of directors mentioned in Articles L.225-

17 and L.225-18 of the French Commercial Code, after being less than or equal to eight, becomes more than eight, the Chair of the Board of Directors shall, within a reasonable period, consult the European works council in order to appoint a second director to represent employees.

If the number of directors mentioned in Articles L. 225-17 and L. 225-18 of the French Commercial Code, after exceeding eight, were to fall to eightor less, the term of office of the director representing employees appointed by the European works council will continue until its term, but shall not be renewed if the number of directors remains less than or equal to eightas at the renewal date.

Article 10.7 of these Articles of Association are not applicable to directors representing employees. Directors representing employees are not taken into account to determine the maximum number of directors set out in Article 10.1 of these Articles of Association.

The term of office of directors representing employees is four years from the date of their appointment. Newly appointed directors representing employees take up office at the expiry of the term of office of the outgoing directors representing employees.

The term of office of the directors representing employees shall legally end in the event of termination of their employment contract with the Company or one of its direct or indirect subsidiaries, dismissal in accordance with Article L. 225-32 of the French Commercial Code or if an event of incompatibility arises as stated in Article L. 225-30 of the French Commercial Code.

In the event that during his or her term of office, for any reason whatsoever (such as death, resignation, dismissal, termination of employment contract), a the seat of a director representing employees becomes vacant, it shall be filled using the same appointment procedures as those described in the third sub-section of this Article 10.9. The term of office of the director thus appointed shall end at the completion of the normal term of office of his or her predecessor. Until the date on which the director representing employees is replaced, the Board of Directors may meet and

24

Eramet - Combined Shareholders' Meeting of 26 May 2020

validly deliberate.

validly deliberate.

The provisions of this section 10.9 shall cease to apply

The provisions of this section 10.9 shall cease to apply

when at the closing of a financial year, the Company

when at the closing of a financial year, the Company

no longer fulfils the prior conditions for the

no longer fulfils the prior conditions for the

appointment of directors representing employees, on

appointment of directors representing employees, on

the understanding that the term of office of any

the understanding that the term of office of any

director representing employees appointed pursuant to

director representing employees appointed pursuant to

this Article 10.9 shall expire at its term.

this Article 10.9 shall expire at its term.

SIXTEENTH RESOLUTION

(Amendment of Article 21 of the Articles of Association)

The General Shareholders' Meeting, acting with the quorum and majority required for Extraordinary Shareholders' Meetings, after reviewing the Board of Directors' report and the provisions of Article L.225- 98 of the French Civil Code resulting from Act 2019-744 of 19 July 2019 (known as the "simplification, clarification and update of company law" Act) resolves to amend Article 21 of the Articles of Association in order to adopt the following text.

Present version

New version

Article 21 - Ordinary General Shareholders'

Article 21 - Ordinary General Shareholders'

Meetings

Meetings

1. The Ordinary General Shareholders' Meeting may

1. The Ordinary General Shareholders' Meeting may

validly deliberate when first called only if the

validly deliberate when first called only if the

Shareholders present, represented or having voted by

Shareholders present, represented or having voted by

mail within the prescribed time, hold at least one-fifth

mail within the prescribed time, hold at least one-fifth

of the shares with voting rights. When called a second

of the shares with voting rights. When called a second

time, no quorum is required, but shareholders may

time, no quorum is required, but shareholders may

deliberate only on issues featured on the agenda of the

deliberate only on issues featured on the agenda of the

first meeting.

first meeting.

The Ordinary General Shareholders' Meeting adopts

The Ordinary General Shareholders' Meeting acts by a

resolutions on the majority of the votes held by the

majority of the votes castby the Shareholders present

Shareholders present or represented, including

or represented, including Shareholders who voted by

Shareholders who voted by mail within the prescribed

mail within the prescribed time.

time.

2. The Ordinary General Shareholders' Meeting listens

2. The Ordinary General Shareholders' Meeting listens

to the reports of the Board of Directors and of the

to the reports of the Board of Directors and of the

Statutory Auditors; it discusses, approves or rectifies

Statutory Auditors; it discusses, approves or rectifies

the parent company financial statements, and as

the parent company financial statements, and as

appropriate, the consolidated financial statements, sets

appropriate, the consolidated financial statements, sets

the dividends, appoints or dismisses Directors and

the dividends, appoints or dismisses Directors and

Statutory Auditors, discharges them from their

Statutory Auditors, discharges them from their

missions, ratifies co-optations of Directors, rules on

missions, ratifies co-optations of Directors, rules on

the agreements submitted for authorisation and passes

the agreements submitted for authorisation and passes

all resolutions on its agenda and which are not within

all resolutions on its agenda and which are not within

the purview of the Extraordinary General

the purview of the Extraordinary General

Shareholders' Meeting.

Shareholders' Meeting.

SEVENTEENTH RESOLUTION

(Amendment of Article 22 of the Articles of Association)

The General Shareholders' Meeting, acting with the quorum and majority required for Extraordinary Shareholders' Meetings, after reviewing the Board of Directors' report and the provisions of Article L.225-96 of the French Civil Code resulting from law 2019-744 of 19 July 2019 (known as the "simplification, clarification and update of company law") resolves to amend Article 22 of the Articles of Association in order to adopt the following text.

25

Eramet - Combined Shareholders' Meeting of 26 May 2020

Present version

New version

Article 22 - Extraordinary General Shareholders'

Article 22 - Extraordinary General Shareholders'

Meetings

Meetings

1. The Extraordinary General Shareholders' Meeting

1. The Extraordinary General Shareholders' Meeting

may validly deliberate when first called only if the

may validly deliberate when first called only if the

Shareholders present, represented or having voted by

Shareholders present, represented or having voted by

mail within the prescribed time, hold at least one-

mail within the prescribed time, hold at least one-

quarter at first call, and one-fifth at second call of the

quarter at first call, and one-fifth at second call of the

shares with voting rights. Absent this last quorum, the

shares with voting rights. Absent this last quorum, the

second Shareholders' Meeting may be postponed by at

second Shareholders' Meeting may be postponed by at

most two months after the date on which it was called.

most two months after the date on which it was called.

The Extraordinary General Shareholders' Meeting

The Extraordinary General Shareholders' Meeting

adopts resolutions on the majority of two-thirds of the

adopts resolutions by a two-thirds majority of the votes

votes held by the Shareholders present or represented,

castby the Shareholders present or represented,

including Shareholders who voted by mail within the

including Shareholders who voted by correspondence

prescribed time.

within the prescribed time.

2. The Extraordinary General Shareholders' Meeting

2. The Extraordinary General Shareholders' Meeting

may amend all the clauses of the Articles of

may amend all the clauses of the Articles of

Association, provided that they do not increase the

Association, provided that they do not increase the

commitments of Shareholders, subject to the

commitments of Shareholders, subject to the

requirement that Shareholders purchase or sell

requirement that Shareholders purchase or sell

fractional shares, in the event shares are combined

fractional shares, in the event shares are combined

capital is increased or reduced, or a merger or split

capital is increased or reduced, or a merger or split

occur.

occur.

UNDER THE AUTHORITY OF THE ORDINARY SHAREHOLDERS' MEETING

EIGHTEENTH RESOLUTION

(Powers)

The General Shareholders' Meeting, acting with the quorum and majority required for Ordinary Shareholders' Meetings, endows the bearer of any original, excerpt or copy of the minutes of this Shareholders' Meeting with full powers to carry out all the necessary filings or formalities.

26

Eramet - Combined Shareholders' Meeting of 26 May 2020

COMPOSITION OF THE BOARD OF DIRECTORS

AS OF FEBRUARY, 19 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

BORIES Christel

Director

and

Expiry

date:

Within group companies:

Director, (5)

Chairman

and

General

• Director of COMILOG S.A.

Chairman

CEO:

General

Shareholders'

• Director of Société Le Nickel SLN

and CEO

Shareholders'

and

Meeting

called to

Born on May, 20 1964

Board

Meeting

of

approve

the 2020

Within non-group companies:

(55 years)

May,

23 2017

financial statements

• Director of Legrand and Smurfit Kappa

French national

(listed companies)

Business address:

Offices held and terminated during

10 Boulevard de

the past five years:

Grenelle

Within Group companies :

75015 Paris

• Director of Smurfit Kappa (listed

company) (until December 2019)

100 Eramet shares held

• Deputy CEO of Ipsen (listed company)

(until 2016)

Within non-Group companies:

• Chairman of Aubert & Duval (from

December 2017 to February 2018), of

Ecotitanium (from December 2017 to

March 2018)

ANTSELEVE Michel

General

Renewal:

Within group companies:

Director

Shareholders'

General

• None

Born on February,19

Meeting of May, 15

Shareholders'

Within non-group companies:

1965 (54 years)

2013

Meeting of May, 23

• Vice Chairman Board of Directors of

Gabonese national

2017, for a four-

Total Gabon since March 2017 (listed

year term

company)

Business address:

Expiry date:

Offices held and terminated during

BP 12905

General

the past five years :

Libreville

Shareholders'

• Director representing the Gabonese

Gabon

Meeting called to

Republic on the Board of Directors of

approve the 2020

Compagnie de Navigation Intérieure

Mr ANTSELEVE is a

financial statements

(Gabon) (until 2013)

senior

civil servant

of

• Director representing the Presidency of

the Gabonese State,

the Gabonese Republic on the Boards of

Professor-Researcher at

Directors of Société de Développement

the

University

of

des Ports (Gabon) (until 2016)

Masuku.

• Director representing the Presidency of

the Gabonese Republic on the Boards of

100 Eramet shares held

Directors of Compagnie Minière de

Belinga (Gabon) and Société Nationale

de Gestion et de Construction du

Logement Social (Gabon) (until the

beginning of 2017)

27

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

BURIN des

General

Expiry date:

Within group companies:

ROZIERS Emeric

Shareholders'

General

None

Director

Meeting of May, 23

Shareholders'

Within non-group companies:

Born on September, 8

2019

Meeting called to

(non-listed companies)

1980 (39 years)

approve the 2022

• Chairman of Endel SAS and of

French national

financial statements

Technical Engineering Support SAS (

Endel subsidiaries)

Business address:

10 Boulevard de

Offices held and terminated during

Grenelle

the past five years :

75015 Paris

• Director of Gulf Chemical and

Metallurgical

Corporation

(until 2016)

M. Burin des Roziers is

(American subsidiary of Eramet)

Chief

Executive

Officer

of

Endel

(An

Engie subsidiary).

1067 Eramet shares

held

COIGNARD

General

Expiry

date:

Within group companies:

Christine

Shareholders'

General

None

Director (1) (4) (5)

Meeting of May, 23

Shareholders'

Born on February 5

2017

Meeting

called to

Within non-group companies:

1964 (55 years)

approve

the 2020

• Director of Polymetal International plc

French

and Canadian

financial statements

(listed company - United Kingdom)

nationals

• Managing director and founding

partner of Coignard & Haas GmbH

Business address:

(Germany)

10 Boulevard de

Grenelle

Offices held and terminated during

75015 Paris

the past five years:

• Managing director of Hatch

Ms

Coignard

is

International

Advisers

Ltd (United

managing

director

and

Kingdom)

founding

partner

of

• Director of Tenetopera Ltd (United

Coignard

&

Haas

Kingdom)

GmbH,

a strategy

and

development

consulting firm.

100 Eramet shares held

28

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

CORBIN François

General

Expiry

date:

Within group companies:

Director (1) (4)

Shareholders'

General

None

Born on September14

Meeting of May, 23

Shareholders'

Within non-group companies

1957 (62 years)

2019

Meeting

called

to

(Non-listed companies):

French national

approve

the

2022

• Director of Medef International

Business adress :

financial statements

(France)

10 Boulevard de

• Director of Medef International (The

Grenelle

Unites States)

75015 Paris

• Director of the "Committee France /

China" (Comité France / Chine)

M. CORBIN is General

Delegate to the

Offices held and terminated during

Chairman of the

the past five years:

Michelin group for

• Chairman of Michelin Ventures SASU

international matters.

(until 2019)

and Vice President of

• Director of the "Michelin Foundation"

MEDEF International

(Fondation Michelin) (until 2019)

in charge of the

coordination in the

ASEAN.

1 Eramet share held

DUVAL Jérôme

General

Expiry

date:

Within group companies:

Director (5)

Shareholders'

General

• None

Born on December 30

Meeting of May, 23

Shareholders'

Within non-group companies:

1972 (47 years)

2019

Meeting

called

to

(Non-listed companies)

French national

approve

the

2022

• None

Business address :

financial statements

10 Boulevard de

Offices held and terminated during

Grenelle

the past five years:

75015 Paris

• None

Cousin of Cyrille

DUVAL and Nathalie

de La FOURNIERE.

M. DUVAL is Director

of Financements

Maritimes Amériques

at Crédit Agricole CIB

600 Eramet shares held

29

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

SORAME

General

Reappointments:

Within group companies:

Administrateur (1) (2)

Shareholders'

General

• Director of Comilog SA and Metal

(3) (5) represented by

Meeting

Shareholders'

Securities

DUVAL Cyrille (as a

of 11 May 2011

Meetings

of

29

Permanent

May

2015 and

of

Within

non-group

companies:

Representative)

23 May 2019, for a

• Chairman of CEIR

Born on 18 July 1948

four-year term

• CEO of SORAME

(71 years)

French national

Expiry

date:

Offices held and terminated during the

Business address :

General

past five years (Group companies) :

10 Boulevard de

Shareholders'

• Manager of SCI Grande Plaine (until

Grenelle

Meeting

called

to

2016)

75015 Paris

approve

the

2022

• Chairman of Forges de Montplaisir

Uncle of

Nathalie

de

financial statements

(until 2016)

La

FOURNIERE,

• Chairman of Brown Europe (until

cousin of Georges and

February 2017)

Edouard DUVAL

• Deputy CEO of Eramet Holding

Mr Duval is CEO of

Alliages (until October 2017)

SORAME and

Chairman of CEIR.

(within non- group companies)

•Director Nexans (until May 2019)

6 041 Eramet shares

held

CEIR

General

Reappointments:

Within Group companies:

Director

represented

Shareholders'

General

• None

by

Meeting

Shareholders'

Within non-group companies :

de

La FOURNIERE

of 11 May 2011

Meetings

of

29

None

Nathalie (5)

May 2015 and of 23

Born on October, 1st

May

2019,

for

a

Offices held and terminated during

1967 (52 years)

four-year term

the past five years (Group companies):

Permanent

None

representative of CEIR

Expiry

date:

on

the

Board

of

General

Directors

Shareholders'

French national

Meeting

called

to

Business Address:

approve

the

2022

10

Boulevard

de

financial statements

Grenelle

75015 Paris

Niece

of

Cyrille

DUVAL,

cousin

of

Georges

and

Édouard

DUVAL

Ms de La

FOURNIERE is

Finance and

Administration

Director of the Agence

d'Urbanisme et

d'Aménagement

Toulouse Aire

Métropolitaine.

100 Eramet shares held

30

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

GAIDOU Frédéric

Appointed by the

Expiry date:

Within Group companies:

Director representing

European Works

November 11, 2022

• None

employees, (2)

Council on 24 April

Within non-group companies :

Born on December, 11

2018 in accordance

• None:

1974 (45 years)

with Article 10.9 of

Offices held and terminated during

French national

the Articles of

the past five years:

Association

None

Business address :

10 Boulevard de

Grenelle

75015 Paris

Mr GAIDOU is

Product Responsibility

Coordinator in the

Communication and

Sustainable

Development

Department.

21 Eramet shares held

GILET Jean Yves

Co-opted by the

Expiry

date:

Within non-Group companies:

Director (5)

Board

on

23

General

Chairman of Gilet Trust Invest SAS

Born on March 9 1956

September 2016

Shareholders'

(63 years)

Meeting

called to

Offices held and terminated during

French national

approve

the 2018

the past five years:

financial statements

Executive Director of Bpifrance (2013-

Business address :

2016)

82 rue de l'Université

Director of CGG Veritas (2014-2015)

75007 Paris

Director of Eiffage (until May 2017)

Director of Orange (until January 2017)

Mr GILET is Chairman

of Gilet

Trust Invest

SAS, a

strategy and

management consulting

company.

100 Eramet shares held

31

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

GOMES Philippe

Director

Co-opted by the

Reappointment:

Within Group companies :

Born on October

Board

on

10

General

• None

271958 (61 years)

December 2014

Shareholders'

Within non-Group companies:

French national

Meeting of 23 May

• None

2017, for a four-

Business address :

year term

Offices held and terminated during

126 rue de l'Université

Expiry

date:

the past five years:

75355 Paris 07 SP

General

Deputy Chairman of STCPI (from 2004

Shareholders'

to 2009)

Mr GOMES is member

Meeting

called

to

• Chairman of the Agence pour la

of Parliament of the

approve

the

2020

Desserte Aérienne de la Nouvelle-

second constituency of

financial statements

Calédonie (ADANC) (from 2009 to

New Caledonia.

2011)

• Chairman of Société Immobilière

101 Eramet shares held

Calédonienne (SIC) (from 2004 to 2009)

• Chairman of Société de Participation

Minière du Sud Calédonien (SPMSC)

(from 2005 to 2009 and in 2014)

• Chairman of the Board of Directors of

ENERCAL (until July 2017)

• Chairman of Nouvelle-Calédonie

Energie (until December 2018)

• Deputy Chairman of STCPI (from 2004

to 2019)

LEPOUTRE

Manoelle

General

Reappointments:

Within Group Companies :

Director (3) (4) (5)

Shareholders'

General

None

Boen on May, 8 1959

Meeting

Shareholders'

(60 ans)

of 11 May 2011

Meeting of May, 29

Within non-Group companies:

2015 and May, 23

(non-listed companies) :

French national

2019, for a four-

Director of Fondation Villette-

Business address :

year term

Entreprises

TOTAL

2 place Jean Millier

Expiry date:

Offices held and terminated during

La Defense 6

General

the past five years:

92078 Paris La

Shareholders'

None

Defense Cedex

Meeting

called

to

approve

the

2022

Ms LEPOUTRE is

financial statements

Director of Civil

Society Commitment

within the TOTAL

group.

100 Eramet shares held

32

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

LETELLIER

Appointed

by

the

Expiry

date:

22

Within Group Companies :

Jean-Philippe

(5)

Central

Works

June 2022

• None

Director

representing

Council as from 23

Within non-Group companies:

employees

June

2018

in

• None

Born

on

January,

19

accordance

with

Offices held and terminated during the

1963

(56

years)

Article

10.9

of

the

past five years:

French

national

Articles

of

• None

Association

Business address

10

Boulevard

de

Grenelle

75015 Paris

Mr Letellier is Energy

Management

Coordinator in the

Energy and Climate

Department.

21 Eramet shares held

MAES Miriam

Appointed

by

the

Expiry

date:

Within Group Companies :

Director (1) (2) (4)

General

General

None

Born on May, 8 1956

Shareholders'

Shareholders'

(63 ans)

Meeting of 27 May

Meeting

called

to

Within non-Group companies

2016

approve

the 2019

Director of Assystem SA (France)

Dutch national

financial statements

(listed company) and Vilmorin & Cie

(France) (listed company)

Business address :

Chairman of the Supervisory Board of

the Port of Rotterdam (Netherlands)

80 St Pancras Way,

Director of Urenco (England) and Ultra

Camden Courtyards,

Centrifuge Netherlands

flat 25, Londres,

Chairman of Foresee (United Kingdom)

NW1 9DN.

Offices held and terminated during the

Ms Maes is.

past five years

Director of Naturex (France) (listed

Mme Maes has held

company) (until September 2018)

executive positions in

Chair of the Board of Directors of Elia

various multinationals.

Asset BV and Elia System Operator BV

(Belgium) (listed company) (until May

100 Eramet shares held

2017)

Chair of Sabien Technology Group Ltd

(United Kingdom) (until 2015)

Director of Kiwi Power Ltd (United

Kingdom) (until 2014)

33

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

MAPOU Louis

Director

Appointed

by the

Expiry

date:

Within Group Companies :

Born on November, 14

General

General

• None

1958 (61 ans)

Shareholders'

Shareholders'

French national

Meeting of 24 May

Meeting

called

to

Within non-Group companies

2018

approve

the

2021

• Chairman of STCPI since 2018

Business address

financial statements

• Director of Promo Sud (financing and

10 Boulevard de

development company of the Southern

Grenelle

Province of New Caledonia)

75015 Paris

• Member of the Supervisory Board of

IEOM

Mr Mapou is a member

of the Southern

Offices held and terminated during

Province Assembly and

the past five years

the Congress of New

Director of ERAMET from March

Caledonia.

2001 to June 2014

CEO of Sofinor (financing and

99 Eramet shares held

investment company of the Northern

Province) until August 2014

-

Chairman

of STCPI

(Société

Territoriale

Calédonienne

de

Participation) until November 2014

Executive Director of the Board of

Directors of KNS (Koniambo Nickel

SAS) until August 2014

RONGE Catherine

Administrateur (2) (4)

Co-opted by the

Reappointment:

Within Group Companies :

Née le 13 avril 1961

Board on

February

General

None

(58 ans)

17 2016

Shareholders'

Nationalité française

Meeting of 23 May

Within non-Group companies :

Adresse

2017, for a four-

Director of the Colas Group (listed

professionnelle

year term

company)

INNEVA

Expiry

date:

Director of Paprec Holding

3 rue de Chaillot

General

Chairman of Inneva

75116 Paris

Shareholders'

Chairman of Weave Air

Meeting

called

to

Vice-Chairman of the Armines

Mme RONGE est

approve

the

2020

Association

Présidente de Weave

financial statements

Air, société de conseil

Offices held and terminated during

en stratégie.

the past five years :

Director of Innoveox (until 2016)

100 actions Eramet

détenues

34

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

SIKORAV Sonia

Director (1) (4) (5)

Appointed by the

Expiry

date:

Within Group Companies :

Born on May 8 1957

General

General

None

(62 years)

Shareholders'

Shareholders'

French national

Meeting of 27 May

Meeting

called to

Within non-Group companies :

2016

approve

the 2019

Director of NSC Groupe and PSB

Business address :

financial statements

(listed companies) (France)

10 Boulevard de

Grenelle

Offices held and terminated during the

75015 Paris

past five years

Director of Eolane (France) - (2009-

Ms SIKORAV is an

2017)

independent director

Director of ENSCP - Ecole Nationale

and has held executive

de Chimie de Paris (until 2014)

management, strategy

management and

procurement

management positions

in various industrial

groups.

100 Eramet shares held

35

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

TENDIL Claude

Director (2) (3) (4)

Co-opted by the

Reappointments:

Within Group Companies :

Born on July 25 1945

Board

on 25

May

• None

(74 years)

2012

(ratified

by

General

French National

the

General

Shareholders'

• Chairman of the Board of GENERALI

Shareholders'

Meeting of May, 29

IARD

Business address :

Meeting of 15 May

2015 and

of May,

• Director of GENERALI France

GENERALI France

2013)

23 2019, for a four-

• Director of GENERALI VIE

2 rue Pillet-Will

year term

• Director of Europ Assistance Holding

75009 Paris

• Director of SCOR SE

Expiry date:

• Chairman of RVS (association)

Mr TENDIL is

General

• Member of the Executive Committee of

Chairman of the Board

Shareholders'

MEDEF

of GENERALI IARD.

Meeting

called to

• Chairman of the Institut pour

approve

the 2022

l'innovation économique et sociale

100 Eramet shares held

financial statements

(2IES)

• Chairman of ARC Foundation for

cancer research Within non-Group

companies :

Offices held and terminated during

the past five years

• Chairman and CEO of Generali France,

Generali Vie, Generali Iard (until

October 2013)

• Chairman of the Board of Europ

Assistance Holding (until 2015) and

Europ Assistance Italy (until April 2015)

• Director of Assicurazioni Generali SpA

• Member of the Supervisory Board of

Generali Investments SpA

• Permanent representative of Europ

Assistance Holding on the Board of

Europ Assistance Spain (until 2014)

• Chairman of the Board of Directors of

GENERALI France, GENERALI France

Assurances and GENERALI Vie (until

2016).

36

Eramet - Combined Shareholders' Meeting of 26 May 2020

Surname, first name

Date of first

Date of last

Other positions held

or company name

appointment

reappointment,

Position

and end date of

Family connection

term of office

Expertise

VINCENT Bruno

Director (1) (2) (3) (5)

Appointed

as

a

Non applicable

Within Group Companies :

Born on March, 6 1982

representative

of

• None

(37 years)

the

State on

May,

French National

23

2019

in

accordance with the

Within non-Group companies :

Business Address :

Ordinance

of

• Director of ORANO SA, and

Agence des

August, 20 2014

of'AREVA SA

Participations de l'Etat

139 rue de Bercy

Offices held and terminated during

Teledoc 229

the past five years :

75012 Paris

• Director of Monnaie de Paris (from

2013 to 2014), Imprimerie Nationale

M. VINCENT is

(from 2013 to 2014), the Grand Maritime

Director-of Energy

Port of La Rochelle (from 2013 to 2014),

Shareholdings at the

the Grand Port Maritime of Marseille

Agence des

(from 2014 to 2017), SNCF Réseau

Participations de l'Etat

(from 2015 to 2017), Aéroports de Lyon

(APE)..

(from 2015 to 2016) and Aéroports de la

Côte d'Azur (from 2014 to 2016)

Number of Eramet

shares held : non

applicable

  1. Audit, Risks and Ethics Committee
  2. Remuneration and Governance Committee
  3. Appointments' Committee
  4. Independent Director
  5. Strategy and CSR Committee

37

Eramet - Combined Shareholders' Meeting of 26 May 2020

  • SAY ON PAY EX ANTE» : Approval of the remuneration policy of the management and administration bodies, pursuant to Articles L. 225-37-2 and R.225-29-1 of the French Commercial Code

Pursuant to the provisions of Article L. 225-37-2 and Article R. 225-29-1 of the French Commercial Code, the General Shareholders' Meeting is called to approve resolution 7 of the remuneration policy applicable to the members of the Board of Directors and resolution 8 the remuneration policy applicable to Ms Christel Bories, Chief Executive Officer. These disclosures are provided in Chapter 7 of the 2019 Universal Registration Document,"Remuneration of the management and administration bodies".

In accordance with the wording of Article L. 225-37-2, the approval of the General Shareholders' Meeting is required every year and upon each material change to the remuneration policy. If the General Shareholders' Meeting does not approve the resolution and if it has previously approved a compensation policy, the latter shall continue to apply and the Board of Directors shall submit a draft resolution presenting a revised remuneration policy to the next General Shareholders' Meeting for approval. In the absence of a previously approved compensation policy, if the General Shareholders' Meeting does not approve the draft resolution, remuneration shall be determined in accordance with the remuneration assigned in the previous year, or, in the absence of remuneration assigned in the previous year, in accordance with existing practices within the Company.

The text of the paragraph 7-1 of the 2019 Universal Registration Document follows below:

7.1. Remuneration policy for the executive corporate officers

Our remuneration policy was drafted by the Board of Directors on 19 February 2020, in accordance with article L.225-37-2 of the French Commercial Code, as amended by Order No. 2019-134 of 27 November 2019 and its implementing decree, based on the proposal by the Remuneration and Governance Committee.

As at the date of this report, the Company's corporate officers are Ms Christel Bories, Chairperson and CEO, and all the members of the Board of Directors.

In accordance with Articles L. 225-37-2 and R. 225-29-1 of the French Commercial Code, the remuneration policy will be put to the 2020 General Shareholders' Meeting for approval in a resolution and will be made public on the Company's website on the next business day after the vote. The public can continue to consult the policy, free of charge, throughout the period it is applicable, together with the date and result of the vote.

7.1.1. Information on all corporate officers

7.1.1.1. Principles for determining the remuneration policy applicable to corporate officers

The Board of Directors ensures that the remuneration policy applicable to corporate officers, proposed by the Remuneration and Governance Committee and approved by the Board, is in the corporate interest, is aligned with the Company's business strategy and is designed to promote our performance and competitiveness over the medium and long term to ensure sustainability.

These are the principles underlying the policy:

38

Eramet - Combined Shareholders' Meeting of 26 May 2020

Compliance

In its analysis and proposals, the Remuneration and Governance Committee pays

special attention to making sure the remuneration policy accords with legal and

regulatory requirements, as well as with the recommendations of the Afep-Medef

Code.

Simplicity and consistency

In drafting the remuneration policy, the Remuneration and Governance Committee

ensures that it proposes simple, intelligible rules that are consistent with those that

apply to Group employees.

Comprehensiveness and

All components of remuneration and benefits of all kinds are exhaustively analysed

balance

each year, with both an approach by component, based on justification and the

interests of the Company and the Group, and an analysis of overall consistency. The

aim is to achieve the best possible balance between fixed and variable, individual

and collective, short and long-term compensation.

Aligning interests

This criterion is predicated on the need to be able to attract, motivate and retain the

talent to execute on the strategy the Company needs, and to meet the requirements of

shareholders and other stakeholders, especially when it comes to CSR and the link to

performance.

Competitiveness

We regularly benchmark remuneration levels and structures against panels of our

corporate peers, with the assistance of external consulting firms.

The international panel is made up of international mining players: Rio Tinto,

Anglo-American, BHP, Vale and Glencore.

In the national market, we use a panel of 120 companies, with a particular focus on

industrial companies.

Performance

Financial and extra-financial performance requirements are stringent and assessed

annually. They encompass the key factors of value creation and the Company's

profitable and sustainable growth and are aligned with our short, medium and long-

term objectives, which contributes to lasting growth. They are regularly reviewed in

line with the Group's strategic priorities.

7.1.1.2. Decision-making process to determine, review and implement the remuneration policy for corporate officers

The policy for the remuneration of corporate officers is determined and reviewed every year by the Board of Directors, on the recommendations of the Remuneration and Governance Committee.

These recommendations are based on analysing market practices and on a yearly survey of the remuneration of corporate officers of companies with a turnover and market capitalisation comparable to that of the Eramet Group.

In its procedures for managing conflicts of interest, Eramet complies with the recommendations of the Afep-Medef Code on the independence of directors that sit on the Remuneration and Governance Committee and the Board of Directors.

All directors are bound by the Directors' Charter appended to Eramet's Internal Regulations, which sets out the directors' obligations with respect to conflicts of interest.

Accordingly, the executive corporate officer concerned (in this case, the Chairperson and CEO) does not take part in the work of the Remuneration and Governance Committee that concerns him/her.

Similarly, the executive corporate officer does not take part in the deliberations or vote on decisions concerning him/her taken by the Board of Directors.

The Remuneration and Governance Committee meets as often as necessary, especially before approving

the "say on pay" agenda item for the Shareholder's Meeting.

39

Eramet - Combined Shareholders' Meeting of 26 May 2020

The Committee is tasked with:

  • deciding on all forms of compensation for corporate officers, including benefits in kind, pensions or retirement benefits, received from any Group company or affiliated company;
  • scrutinising and formulating proposals to the Board of Directors on the remuneration of corporate officers and, in particular, the fixed portion, the variable portion, medium- and long-term remuneration plans (including performance shares), as well as pension plans and the contractual terms and conditions relating to their termination of employment (including the fixed portion and the variable portion of remuneration);
  • proposing the principles for determining how directors' fees should be allocated amongst the directors;
  • proposing the total annual sum allocated to the directors, the breakdown of individual amounts, as well as the remuneration allocated to the directors tasked with exceptional assignments.

The Chairman of the Remuneration and Governance Committee reports to the Board of Directors on the Committee's work, studies and recommendations.

Under its remit, the Remuneration and Governance Committee may request technical studies relating to the compensation of corporate officers from any outside advisor, consultant or expert.

The Board of Directors decides on the remuneration policy applicable to the corporate officers and oversees implementation. It sets the remuneration for Eramet's Chairperson & CEO and directors. Moreover, as part of its preparatory work for the annual review of the remuneration of corporate officers, the Remuneration and Governance Committee is informed about the changes proposed for the Group's employees as a whole, both in terms of fixed and variable compensation and the allocation of shares, with or without performance conditions. This information is designed to ensure that the policy for corporate officers is aligned and consistent with the remuneration policy for Group employees.

7.1.1.3. Breakdown of fixed annual remuneration granted to directors

The total sum allocated to the Board of Directors was set at €950,000 at the General Shareholders' Meeting of 23 May 2017 (seventeenth resolution).

From 2017 onwards, and in accordance with recommendation 20.1 of the Afep/Medef Code the rules for the allocation of Eramet's directors' fees are as follows, to ensure the amount consists primarily of a variable portion:

  • €10,000 per year per member of the Board of Directors.
  • €5,000 per member of the Appointments Committee, no annual fee for members of the Strategy and CSR Committee, for members of the Audit, Risks and Ethics Committee or for members of the Remuneration and Governance Committee.
  • Payment of €2,500 for each attended meeting of the Board of Directors, each attended meeting of the Strategy and CSR Committee and each attended meeting of the Remuneration and Governance Committee. This amount is increased to €5,000 for the chairman of each of these two committees.
  • Payment of €3,000 for each attended meeting of the Audit, Risks and Ethics Committee. This amount is increased to €6,000 for the chairman of the committee.
  • No fees are paid for attendance at Appointments Committee meetings.
  • There is no annual limit per Board or Committee.
  • A travel allowance of €1,525 is paid to each director living outside Europe for each trip to attend a Board or Committee meeting.

40

Eramet - Combined Shareholders' Meeting of 26 May 2020

7.1.1.4. Applying the remuneration policy

a. How we assess performance criteria

i. Variable remuneration of the Chairperson and CEO

Annual variable remuneration is currently set by the Board of Directors at the end of the financial year to which it applies. During the fourth quarter of the year, on a recommendation of the Remuneration and Governance Committee, the Board reviews the targets, their weighting and expected performance. It sets:

  • the threshold below which no variable remuneration is paid;
  • the target variable remuneration due when all targets are met; and
  • the criteria for evaluating quantitative performance. Accordingly:
  • 100% of the bonus is paid when targets are met;
  • 150% of the bonus may be paid if these targets are exceeded.

Economic performance targets based on financial indicators are set precisely according to a budget approved in advance by the Board of Directors. They are subject to the performance thresholds referred to above. They are identical to those that apply to the Group's key executives and managers. The rate of achievement for each criterion is communicated separately when performance has been reviewed by the Board.

ii. Share-based remuneration of the Chairperson and CEO

The share-based payment plan for the Chairperson and CEO, which is identical to the plan in place for the Group's key executives and managers is based on both intrinsic and extrinsic performance criteria. These criteria for 2020 are detailed in 7.1.2.1.b.iii.

Intrinsic performance targets based on financial indicators are set precisely according to a budget approved in advance by the Board of Directors. During the fourth quarter of the year, on a recommendation of the Remuneration and Governance Committee, the Board reviews the targets, their weighting and expected performance. It sets:

  • the threshold below which no share vests;
  • the target share acquisition level when each target is met.

Accordingly:

  • 100% of allocated shares vest when the targets are met;
  • 150% of allocated shares may vest if these targets are exceeded.

The quantitative performance criteria for long-term remuneration are assessed by the Remuneration and Governance Committee during the first quarter on the basis of the detailed figures in the annual financial statements approved by the Statutory Auditors.

The extrinsic performance criterion is assessed by an external firm, Forward Finance. Their detailed assessment is sent every year to the Remuneration and Governance Committee.

b. Appointment of new corporate officers

If a new Chairperson and CEO were appointed, the same principles, criteria and remuneration components in the policy for the remuneration of the Chairperson and CEO would apply.

If one or more Deputy CEO's were appointed, the principles and criteria for the calculation, breakdown and allocation of remuneration components in the remuneration policy for the Chairperson and CEO would apply to them. On a recommendation of the Remuneration and Governance Committee, the Board of Directors would then decide, based on their individual positions, on the targets, performance levels, parameters, structures and maximum percentages of fixed remuneration to consider, which may not be higher than those applied to the Chairperson and CEO.

41

Eramet - Combined Shareholders' Meeting of 26 May 2020

If the Chairman of the Board of Directors and Chief Executive Officer are separate positions, the Chairman of the Board will be remunerated on the same basis as the directors and will receive fixed remuneration, the amount of which will be determined based on their individual positions and responsibilities.

If a CEO is appointed, the remuneration policy for the Chairperson and CEO will apply in principle, tailored to the individual's position, the targets, performance levels, parameters, structure and maximum percentage of fixed annual remuneration, which may not be higher than those that apply to the Chairperson and CEO.

Moreover, pursuant to Article 24.4 of the Afep-Medef Code, if a new executive is appointed from a company outside the Eramet Group, the Board of Directors may decide to grant them an onboarding allowance (in cash and/or shares) to compensate for the loss of previous remuneration or benefits (excluding pension benefits).

Such remuneration may be paid or implemented subject only to the approval of the Shareholders' Meeting pursuant, to article L. 225-37-2 of the French Commercial Code.

In addition, if the Chief Executive Officer were to be appointed as a Company director, no compensation would be paid for this office.

If a new director were appointed, the same principles, criteria and remuneration components in the policy for the remuneration directors would apply.

c. Changes to the remuneration policy in 2019

The remuneration policy in force at the company during fiscal 2019, which was approved by the General Shareholders' Meeting on 23 May 2019, was clarified to comply with the terms of the Order and decree of 27 November 2019.

It states in its fifteenth resolution that the General Shareholders' Meeting, held on 23 May 2019, approved the criteria for the calculation, breakdown and allocation of the fixed, variable and exceptional components of the total remuneration and benefits of all kinds payable in 2019 to the Chairperson and CEO on a 99.2% basis, without debate.

7.1.2. Information about each corporate officer

7.1.2.1. Remuneration policy applicable in 2020 to the Chairperson and CEO a. Term of office of the Chairperson and CEO

Christel Bories was appointed Chairperson and CEO with effect from 23 May 2017, for the duration of her term of office as director, until the General Shareholders' Meeting called to approve the financial statements for the 2020 financial year.

The Chairperson and CEO may be dismissed at any time by the Board of Directors.

b. Total remuneration and benefits of any kind

  1. Fixed remuneration

The Chairperson and CEO receives a fixed remuneration in consideration for the responsibilities attached to this type of corporate office. The remuneration is determined mainly on the basis of the following:

  • level of responsibility and complexity of the assignments attached to this position,
  • skills, professional experience, expertise and background of the incumbent
  • market research on the remuneration for similar positions at French companies with revenues and market capitalisation comparable to those of the Group. By conducting such research, the Group seeks to position itself in the market median of comparable companies.

42

Eramet - Combined Shareholders' Meeting of 26 May 2020

The fixed remuneration of the Chairperson and CEO was defined as part of her appointment as Chairperson and CEO on 23 May 2017. It amounts to €800,000 (annual gross fixed amount) and has remained unchanged since that date.

However, the fixed remuneration of the Chairperson and CEO is reviewed each year, and its revision may be proposed in the event of significant change to the incumbent's scope of responsibility or discrepancy with respect to the company's market positioning, on the basis of the remuneration surveys carried out each year.

ii. Annual variable remuneration

The objective of the annual variable remuneration is to provide an incentive to the Chairperson and CEO to attain the annual performance objectives set by the Board of Directors in line with the implementation of the company's strategy.

The target-based annual variable portion is set at 100% of gross annual fixed remuneration and can vary from 0% to 150% of gross annual fixed remuneration depending on the level of achievement of the various objectives, with 100% of the fixed rate corresponding to 100% achievement of the objectives. It may not exceed 150% of gross annual fixed remuneration. The variable portion for objectives achieved and the maximum variable portion are reviewed each year by the Remuneration and Governance Committee in relation to market practice, as part of the remuneration surveys conducted annually.

The annual variable remuneration of the Chairperson and CEO, identical to the one applied to the Group's executives and managers everywhere in the world, is determined:

  • 50% on the basis of the quantitative objectives relating to the Group's financial performance during the previous year. For 2020, the adopted performance indicator is the Group's operational cashflow.
  • 10% on the basis of the quantitative objectives relating to the safety of the Group's administrative staff, temporary workers and subcontractors (workplace accident frequency rate);
  • 40% on the basis of annual qualitative objectives.

For 2020, the COI criterion, previously used in the Chairperson and CEO's annual variable remuneration and for all the Group's executives and managers, has been cancelled. The entirety of the variable portion on financial objectives will be based on the operational cash-flow criterion. Due to the changes to the Group's financial ratios, management launched an action plan in 2020 covering the components of cash-generating items. The objectives of the 2020 variable portion are therefore consistent with this focus and will be applied to all Group executives and managers.

Qualitative objectives are determined by the Board of Directors at the proposal of the Remuneration and Governance Committee and focus on strategic, business and managerial issues specific to the next financial year. They may concern the implementation of strategic orientations approved by the Board of Directors, major industrial and commercial developments and programmes, organisational and management actions and achievements that are part of the Group's corporate social responsibility (CSR) and sustainable development approach. They do not fall under routine tasks but are specific actions for which the Board of Directors expects a particular performance.

The 2020 objectives for the Chairperson and CEO break down as follows:

Indicator

Weighting

Financial quantitative objective

Group operational cash flow

50%

Workplace accident frequency rate with or without

lost days, including the accidentology of Eramet

Safety objective

employees, temporary workers and subcontractors.

10%

In the event of a fatal accident at a site, the

achievement rate is divided in half. Beyond that, the

achievement rate is considered nil.

43

Eramet - Combined Shareholders' Meeting of 26 May 2020

• Scale up key achievements of the 2020 strategic

roadmap, while ensuring a secured financial path.

Qualitative objectives

Ensure that the organisation's momentum

40%

continues.

Propose solutions for assets in trouble

These criteria contribute to the remuneration policy objectives, insofar as:

  • the performance criteria are stringent and correspond to the Group's key profitable and sustainable growth factors and are generally aligned with the short- and long-term objectives and priorities of the Eramet Group.
  • the performance criteria include Eramet's performance with respect to the Group's Social
    Responsibility, whether through performance in workplace safety and environment, or through more qualitative annual objectives.
  • The performance criteria are consistent with those of all of the Group's executive employees and managers, thereby aligning all key employees with the interests of shareholders to help achieve sustainable and profitable growth for the Eramet Group.

The annual variable remuneration is calculated and set by the Board of Directors at the end of the financial year to which it applies. To this end, each year, during the first quarter, the Board of Directors, on the recommendation of the Remuneration and Governance Committee, examines the different objectives, their weighting and the anticipated performance levels that are set:

  • the threshold below which no variable remuneration is paid:
  • the target level of the variable remuneration due when each objective is reached; and
  • the quantitative performance assessment criteria.

As such:

  • 100% of the bonus is paid when the objectives are reached;
  • 150% of the bonus may be paid if these objectives are exceeded.

The economic performance objectives measured by financial indicators are specifically set on the basis of the budget previously approved by the Board of Directors and are subject to the performance thresholds mentioned above. The achievement level of objectives is communicated for each criterion once the performance assessment has been made by the Board of Directors.

The Company cannot demand that the annual variable remuneration be returned.

The variable portion owed in a given year is determined by the Board of Directors approving the financial statements for the same year. Thus, in accordance with Article L. 225-100 of the French Commercial Code, payment of the variable portion due for 2020 will be subject to ex post vote by the Shareholders' Meeting called in 2021 to approve the financial statements for the 2020 financial year. It is paid within the month following the validation of this payment by the General Shareholders' Meeting.

There is no other period of potential postponement

iii. Long-term remuneration

The Chairperson and CEO's long-term remuneration is exclusively based on the share grants contingent on performance conditions.

Share-based remuneration is in line with the objectives of the remuneration policy, since it allows the Company to retain its executives and encourages aligning their interests with the Group's corporate interests and the interests of shareholders.

The Chairperson and CEO is granted a maximum of 15,000 performance shares when all the plan performance conditions are exceeded. When the performance conditions are reached at the level of the budget target, definitively vested shares correspond to an envelope of 10,000 shares. The level of this share grant is subject to analysis, renewed at least every three years to ensure that it corresponds to best market practices and, under all circumstances, to AFEP MEDEF guidelines. A revision in the number of shares granted may be proposed in the event of a material change to the Chairperson and CEO's scope of

44

Eramet - Combined Shareholders' Meeting of 26 May 2020

responsibility, a discrepancy with respect to the Company's market positioning, on the basis of the remuneration surveys carried out, or a material change to the Eramet share price.

Share grants are awarded annually at the same time of year and are not discounted. Since these concern existing shares as opposed to new shares, there is no share dilution. With regard to the dilution of voting rights, the allocation of existing shares only has a marginal impact, given the composition of Eramet's equity, on one hand, and the selectivity of the criteria established for these plans, on the other. The share plan regulations prohibit hedging operations and executive corporate officers give a formal undertaking in this respect.

Granted shares are contingent on performance conditions as described below as well as a continuous three- year presence condition for the Group's employees. Vested shares at the end of the three-year vesting period are then subject to an additional two-year holding period for securities.

Furthermore, since the Board meeting of 23 July 2007, corporate officers are required to hold 20% of shares vested in the context of performance share plans throughout their entire term of office.

Performance conditions

Share grant performance conditions are calculated over three years and are identical to those imposed on other Eramet Group beneficiary executives and managers. These performance condition indicators are reviewed at least every three years, after analysing the practices of comparable companies on the market, and to ensure alignment and consistency between long-term remuneration and the Eramet Group's strategy.

In 2020, performance conditions are based on four indicators:

  • the relative performance of Eramet shares for 30% of the share grant (this involves comparing the change in total shareholder return over a three-year period with that of a panel comprised of several dozens of comparable companies on the Euromoney Global Mining Index; Diversified Metals & Mining, Steel; this performance condition is 100% achieved if Eramet ranks between the 30th and 45th percentile, and 150% in the case it ranks among the top 15% of the panel)
  • The intrinsic performance carried out by third parties over three years of the two economic indicators for 50% of the share grant: 25% of EBITDA (Earnings before interest, taxes, depreciation and amortization) and 25% of the net debt. Annual objectives correspond to the
    Group's budget objectives for the year. This performance condition is only met at 150% if these objectives are significantly exceeded.
  • Group Eramet's CSR performance over three years for 20% of the share grant. This is the achievement rate of the Group's CSR roadmap, which is based on 13 indicators that can be broken down into 15 objectives that must be reached, mainly covering the following areas: safety, training and commitment of employees, diversity, energy transition, respect for human rights, reduction of atmospheric emissions and CO2 emissions, responsible procurements, etc.

The remuneration and Governance Committee evaluates the quantitative performance criteria of this long- term remuneration on the basis of the quantified components of the annual financial statements validated by the Statutory Auditors (EBITDA, net debt). Forward Finance, an external firm, performs the assessment of the relative performance criteria of the Eramet share with respect to the Euromoney Global Mining Index panel of companies.

Achievement of the CSR roadmap objectives assessed annually by the Strategy and CSR Committee.

45

Eramet - Combined Shareholders' Meeting of 26 May 2020

Respective weight of remuneration components

The remuneration policy for the Chairperson and CEO aims to strike a balance between long-term and short-term performance in order to promote the development of the Eramet Group for all of its stakeholders.

The total target and maximum remuneration for the Chairperson and CEO breaks down as follows

The long-term variable remuneration below is valued on the basis of the IFRS value during the share grant by the Board of Directors of 20 February 2019.

Severance package

The corporate office of the Chairperson and CEO states that in case of dismissal (except for gross misconduct) or forced resignation, particularly following a change of company control or substantial imposed changes to the scope of responsibility, the Chairperson and CEO will be awarded severance pay equal to one year of her gross fixed and variable remuneration.

To comply with the objectives of the remuneration policy, this package is subject to the condition that the sum of gross variable remuneration received over the last three complete years of her term of office must be 35% or more of the total gross annual fixed remuneration received during the same three-year period. The calculation of this variable compensation is based on stringent performance conditions determined by the Board of Directors at the proposal of the Remuneration and Governance Committee. These conditions include the financial objectives that correspond to the development objectives of the Eramet Group, an objective of corporate responsibility based on the workplace accident rate with lost days and qualitative objectives concerning strategic, business and managerial challenges specific to the financial year. They may concern the implementation of strategic orientations approved by the Board of Directors, major industrial and commercial developments and programmes, organisational and management actions and achievements that are part of the Group's corporate social responsibility (CSR) and sustainable development approach.

In the event that the number of full years is less than three, the performance will be assessed based on the actual duration of the term of office, at the discretion of the Board of Directors at the proposal of the Remuneration and Governance Committee.

The Board of Directors can unilaterally cancel this severance package.

46

Eramet - Combined Shareholders' Meeting of 26 May 2020

Supplementary insurance scheme and healthcare plan

The Chairperson and CEO is covered by the supplementary insurance scheme and healthcare plan in force within the Company under the same conditions as those applicable to other employees.

The supplementary healthcare plan which is 56% financed by Eramet and 44% by beneficiaries, covers the hospitalisation, medical costs, dental and optical costs of beneficiaries and their assigns.

The supplementary insurance scheme, which is 67% financed by Eramet and 33% by beneficiaries, provides coverage in the event of lost days due to illness or accident, a disability allowance, as well as capital or income proportional to the gross annual pay in the event of death.

Insurance contracts related to these schemes can be cancelled under applicable statutory law conditions.

Furthermore, the Board of Directors may unilaterally revisit whether these schemes shall apply to the Chairperson and CEO.

Supplementary pension plan

The Chairperson and CEO is covered by a life insurance policy pursuant to Article 82 of the French General Tax code, designed to supplement the level of the Chairperson and CEO's replacement income when she retires.

The annual amount paid in respect of this policy is 30.39% of the gross total annual remuneration (fixed remuneration + variable remuneration subject to performance conditions) paid to the Chairperson and CEO during the reference year.

The amount thus determined shall be paid in two instalments:

  • Payment by the Company to an insurance company of an annual contribution, up to 50% of the total amount of the additional remuneration
  • Annual payment by the Company to Chairperson and CEO of an amount in cash, up to 50% of the total amount of the additional remuneration, to finance the corresponding social security and tax charges.

The subscription of the life insurance policy was authorised by the Board of Directors on 26 July 2017 and approved by the General Meeting of 24 May 2018 under the procedure for regulated agreements (Article L. 225-38 et seq. of the French Commercial Code). Insurance policies related to these schemes can be cancelled under the statutory law conditions applicable in the field.

To comply with the objectives of the remuneration policy, the basis for calculating this additional remuneration includes fixed and variable remuneration and is therefore de facto subject to performance conditions, which are described above.

c. Absence of other remuneration items

Non-competition commitment

There is no provision for the Chairperson and CEO to receive payment in respect of a non-competition commitment upon conclusion of their respective terms of office.

Compensation for term of office as Director

The Chairperson and CEO does not receive any compensation for the terms of office held within the Group's companies.

47

Eramet - Combined Shareholders' Meeting of 26 May 2020

Exceptional remuneration

The principle of an exceptional remuneration does not exist.

Company car

The Eramet Group's remuneration policy provides that the Chairperson and CEO and other Group executives shall be provided a company car.

The Chairperson and CEO has waived the benefit of this company car.

Employment or provision of services contracts

The Chairperson and CEO does not have an employment contract nor a service contract.

7.1.2.2. Remuneration policy applicable in 2020 to directors

a. Term of office of directors

Directors are appointed for a term of four years in office.

Christel Bories

Appointed on 23 May 2017

Expiry date SM convened for

2020 financial statements

Michel Antsélévé

Appointed on 15 May 2013

Expiry date SM convened for

2020 financial statements

Emeric Burin des Roziers

Appointed on 23 May 2019

Expiry date SM convened for

2020 financial statements

Christine Coignard

Appointed on 23 May 2017

Expiry date SM convened for

2020 financial statements

François Corbin

Appointed on 23 May 2019

Expiry date SM convened for

2020 financial statements

Jérôme Duval

Appointed on 23 May 2019

Expiry date SM convened for

2020 financial statements

Sorame (Cyrille Duval)

Appointed on 11 May 2011

Expiry date SM convened for

2020 financial statements

Nathalie de La Fournière (CEIR)

Appointed on 11 May 2011

Expiry date SM convened for

2020 financial statements

Frédéric Gaidou

Director appointed to represent employees

Expiry date SM convened for

2020 financial statements

Jean-Yves Gilet

Appointed on 23 September 2016

Expiry date SM convened for

2020 financial statements

Philippe Gomes

Appointed on 10 December 2014

Expiry date SM convened for

2020 financial statements

Manoelle Lepoutre

Appointed on 11 May 2011

Expiry date SM convened for

2020 financial statements

Jean-Philippe Letellier

Director appointed to represent employees

Expiry date SM convened for

2020 financial statements

Miriam Maës

Appointed on 27 May 2016

Expiry date SM convened for

2020 financial statements

Louis Mapou

Appointed on 24 May 2018

Expiry date SM convened for

2020 financial statements

Catherine Ronge

Appointed on 17 February 2016

Expiry date SM convened for

2020 financial statements

Sonia Sikorav

Appointed on 27 May 2016

Expiry date SM convened for

2020 financial statements

Claude Tendil

Appointed on 25 May 2012

Expiry date SM convened for

2020 financial statements

Appointed as State representative on 23

Bruno Vincent

May 2019 in accordance with the 20

No expiry date

August 2014 order

The director can be dismissed at any time by resolution of the Shareholders' Meeting.

48

Eramet - Combined Shareholders' Meeting of 26 May 2020

b. Total remuneration and benefits of any kind

Fixed remuneration

Directors receive an annual package compensation of €10,000

Depending on cases, Directors receive the following compensation:

  • an annual package of €5,000 for Appointments Committee members.
  • compensation of €2,500 for each attended meeting of the Board of Directors, the Strategy and CSR Committee and the Remuneration and Governance Committee. This amount is increased to €5,000 for the chairman of each of these two committees.
  • Compensation of €3,000 for each meeting of the Audit, Risks and Ethics Committee attended. This amount is increased to €6,000 for the chairman of the committee.

The directors holding this post in Eramet subsidiaries, Cyrille Duval and Edouard Duval are paid in accordance with the rules defined by each of these companies.

Travel allowance

Each director who is a non-European resident receives a travel allowance of €1,525 for each journey to attend a Board or Committee meeting.

Absence of other remuneration items

Directors do not receive variable or exceptional remuneration, nor share-based payments.

The above remuneration procedures apply to all Eramet directors.

Employment or service contracts

Directors do not, under any circumstances, have an employment contract nor a service contract with Eramet.

49

Eramet - Combined Shareholders' Meeting of 26 May 2020

  • SAY ON PAY EX POST » : Approval of the provisions mentioned in Paragraph I of Article L.225-37-3 of the French Commercial Code - Fixed, variable and exceptional elements comprising the total remuneration and benefits of any kind paid for the year ended to the Chief Executive Officer subject to the shareholders'approval

Pursuant to the provisions of Article L. 225-37-3 paragraph I of the French Commercial Code, the General Shareholders' Meeting is called in resolution 9, to approve the information mentioned in Article L. 225-37- 3 paragraph I of the French Commercial Code. These disclosures are provided in Chapter 7, paragraphs

7.2.1 and 7.2.2 of the 2019 Universal Registration Document, "Remuneration of the management and administration bodies". Pursuant to the provisions of Article L. 225-100 paragraph III of the French Commercial Code, the General Shareholders' Meeting is called in resolution 10, to approve the fixed, variable and exceptional components of the remuneration and benefits of any kind, paid in the past financial year or assigned in the same financial year to Ms Christel Bories, Chief Executive Officer in respect of the 2019 financial year. These disclosures are provided in Chapter 7, paragraph 7.2.3 of the 2019 Universal Registration Document, "Remuneration of the management and administration bodies".

The text of the paragraph 7-2 of the 2019 Universal Registration Document follows below:

  1. Annual total remuneration of the Chairperson and CEO in respect of the 2019 financial year
  1. Total remuneration and benefits of any kind a. Remuneration items
  1. Fixed remuneration

For the 2019 financial year, Christel Bories received gross fixed remuneration of €800,000. This

remuneration is identical to the sum received in 2018.

ii. Variable remuneration

The gross variable remuneration paid in 2019 on behalf of the 2018 financial year was 566,160 euros. This remuneration was approved by the shareholders at the AGM on 23 May 2019 (16th resolution).

The gross variable remuneration owed on behalf of the 2019 financial year is 736,000 euros. The amount of the variable remuneration was determined according to the achievement level of the objectives described below:

Achievement level of 2019 objectives for variable remuneration paid in 2020

Objectives

Weighting

Achievement rate

Percentage paid in

respect of this objective

COI

25%

60%

15%

Operating cash flow

25%

150%

37.5%

Safety (AF2 including employees, temporary workers

10%

0%2

0%

and subcontractors)

2 Despite the objective achievement rate above 150%, four fatal accidents occurred in 2019 resulting in assigning an achievement rate of 0% for this objective.

50

Eramet - Combined Shareholders' Meeting of 26 May 2020

Qualitative objectives linked in particular to the

40%

99%

39.5%

implementation of major Group projects and the

continued rollout of the transformation programme.

Overall objectives achievement rate

100%

92%

92%

The Company did not demand that a variable remuneration be returned.

iii. Exceptional remuneration

Christel Bories does not receive any exceptional remuneration.

iv. Long-term remuneration

The Board of Directors' meeting of 20 February 2019 granted Christel Bories 15,000 performance shares (i.e. 0.06% of the share capital), at an estimated value of €785,550 using the method adopted for the consolidated financial statements (fair value of the share on the day of the shares granted by the Board of Directors) where all the plan performance conditions are exceeded A target number of 10,000 shares corresponds to the number of shares that may be definitively vested three years following granting provided that the performance conditions are fully met. Furthermore, these performance shares are subject to an additional two-year holding period and 20% of these shares are prohibited from sale until the end of the corporate officer's term of office.

These very rigorous performance conditions are calculated over a three-year period, as follows:

  • the relative performance of Eramet shares for one-third of the share grant (this involves comparing the change in total shareholder return over a three-year period with that of a panel of around 37 comparable companies on the Euromoney Global Mining Index; Diversified Metals & Mining, Steel; this performance condition being achieved at 100% in case of ranking between the 30th and 45th percentile and 150% if the Eramet share is ranked among the top 15% of the panel); and
  • the intrinsic performance of certain financial indicators achieved in three instalments over a three year period for two-thirds of the share grant (equal to one-third of EBITDA and one-third of ROCE, the annual objectives referring to the Company's budgetary targets); this performance condition is only met at 150% when the targets are significantly out-performed.

Christel Bories was not granted any other long-term remuneration item during the financial year ended 31 December 2019.

v. Other remuneration items

Social protection scheme

Christel Bories benefits from the supplementary healthcare plan and the supplementary disability and life insurance scheme operating within the Eramet Group.

In 2019:

The employer contribution to the healthcare plan amounted to €1,227.12

The employer contribution to the supplementary life insurance scheme amounted to €7,390.80

51

Eramet - Combined Shareholders' Meeting of 26 May 2020

Life insurance (article 82)

Christel Bories is covered by a life insurance policy pursuant to Article 82 of the French General Tax code, designed to supplement the level of the Chairperson and CEO's replacement income when she retires. This policy guarantees that savings will be set aside which, on the retirement date, will be converted into a life annuity or paid as a lump sum.

The supplementary remuneration prompts the following two payments:

  • The financing of a life insurance contract:

The Company has arranged for Christel Bories to join a life insurance policy underwritten by the Company with an approved insurance company. This contract, known as "Article 82", is an individual life insurance contract. The financing of this contract is fully covered by the Company and represents 50% of the additional remuneration determined in accordance with the above. It does not constitute a retirement commitment.

  • An annual cash payment:

Each year, the company pays a cash amount equal to 50% of the additional remuneration determined in accordance with the above provisions, in order to cover the related social and tax charges.

The annual amount of the additional remuneration paid is 30.39% of the total gross annual remuneration (fixed + variable) paid to Christel Bories during the reference year. The basis for calculating this additional remuneration includes not only fixed remuneration but also variable remuneration. For the 2019 financial year, the employer contribution paid by the Company amounted to €415,176, which breaks down into €207,588 paid to the insurer and €207,588 paid to Christel Bories to offset the related social and tax charges.

The company's commitment is limited to the payment of the contribution mentioned above and it remains free to terminate this contract at any time.

vi. Other forms of remuneration

Christel Bories did not receive any of the following remuneration:

  • Deferred variable remuneration,
  • Multi-yearvariable remuneration,
  • Benefits in kind.
    1. Remuneration allocated to directors

Christel Bories did not receive any remuneration in respect of her term of office as director.

b. Remuneration paid by a company in the scope of consolidation

Christel Bories did not receive any remuneration paid by a company in the scope of consolidation.

c. Respective weight of remuneration items

Relative proportion of fixed and variable remuneration

Amount

Portion

Fixed remuneration

800,000

52%

Annual variable remuneration

736,000

48%

52

Eramet - Combined Shareholders' Meeting of 26 May 2020

7.2.1.2. Fairness ratio and changes in performance

The fairness ratio between the remuneration level of the Chairperson and CEO and the average and medial remuneration of Eramet SA employees

The following presentation was performed in accordance with the provisions of French ordinance no 2019- 1234 of 27 November 2019 and the AFEP guidelines.

To prepare this information, we chose the scope of the listed company Eramet SA.

2015

2016

2017

2018

2019

Fairness ratio on median wage

39.4

21.1

24.6

36.9

24.3

Fairness ratio on median wage

23.7

15.0

16.8

22.1

16.4

Explanations for the change of ratios:

  • Patrick Buffet was Chairperson and CEO throughout all of financial years 2015 and 2016.
  • Christel Bories was Chairperson and CEO throughout all of financial years 2018 and 2019.
  • For the 2017 financial year, the ratio was calculated on the basis of total remunerations paid to Patrick Buffet until the end of the term of office on 23 May 2017 and Christel Bories as from the start of her appointment on 23 May 2017.

Comparison of the changes to these remunerations with the change in the performance of the Eramet group:

2015/2016

2016/2017

2017/2018

2018/2019

Remuneration of the Chairperson

-44%

43%

31%

-31%

and CEO

Eramet SA average remuneration

-12%

28%

0%

-7%

EBITDA*

308%

132%

-3%

-25%

  1. The data presented is adjusted data from the Group's reporting, in which the operating performance of the joint ventures is recognized under proportionate consolidation until 2018: the TiZir subgroup (Mineral Sands BU, Mining and Metals Division) until 30 June and UKAD (High Performance Alloys Division) until 31 December

7.2.1.3. Taking into account the Shareholders' Meeting's last global ex post vote

Not relevant given that this vote, created by the French ordinance of 27 November 2019, was not applied

until the last Shareholders' Meeting.

7.2.1.4. Compliance of the remuneration paid with the remuneration policy

The remuneration items of Christel Bories described below are compliant with the provisions defined by the Board of Directors, on the recommendation of the Remunerations Committee. They are determined in

compliance with the corporate interest, as tailored to Company's commercial strategy, and correspond to a policy of performance and competitiveness in the medium and long term to ensure the Company's

longevity.

The financial performance and non-financial performance conditions are stringent and assessed on an annual basis. They correspond to the Company's key value-creation and profitable, sustainable growth

53

Eramet - Combined Shareholders' Meeting of 26 May 2020

factors and align with its short-, medium- and long-term objectives, which contributes to its longevity. They are reviewed regularly in light of the Group's strategic priorities.

Share grant performance conditions are calculated over three years and are identical to those imposed on other Eramet Group beneficiary executives and managers.

The Board of Directors determines the remuneration applicable to corporate officers and ensures their implementation. It sets the remuneration of Eramet's Chairperson and CEO and directors. Furthermore, as part of the work involved in preparing for the annual review of the remuneration of corporate officers, the Remuneration and Governance Committee receives information on the trending criteria proposed for the Group's employees overall, both with respect to fixed and variable remuneration and granting of shares regardless of whether or not they are contingent on performance conditions. This information ensures alignment and consistency between the provisions applicable to corporate officers and those applicable to the Group's employees.

The Company did not deviate from the remuneration policy implementation procedure.

The Company did not waive the remuneration policy.

7.2.1.5. Suspension of the remuneration paid to directors

As the Board of Directors is organised in accordance with the provisions of Article L. 225-18-1 of the Commercial Code, payment of the compensation set out in the first sub-paragraph of Article L. 225-45 of the aforesaid code has not been suspended.

  1. Total annual remuneration of the directors in respect of the 2019 financial year
  1. Total remuneration and benefits of any kind a. Remuneration items

Table 3 provides details on the items of the directors' remuneration in respect of financial year 2019.

b. Remuneration paid by a company in the scope of consolidation

With the exception of Cyrille Duval as mentioned in Table 3, directors received no remuneration from a company in the scope of consolidation.

c. Respective weight of remuneration items

Directors did not receive any variable or exceptional compensation in respect of the 2019 financial year.

7.2.2.2. Taking into account the Shareholders' Meeting's last ex post vote

Not applicable given that this vote, created by the French ordinance of 27 November 2019, was not applied until the last Shareholders' Meeting.

7.2.2.3. Compliance of the remuneration paid with the remuneration policy

Not applicable given that no remuneration policy had been defined for directors prior to the 27 November 2019 ordinance.

7.2.2.4. Suspension of the remuneration paid to directors

As the Board of Directors is organised in accordance with the provisions of Article L. 225-18-1 of the Commercial Code, payment of the compensation set out in the first sub-paragraph of Article L. 225-45 of the aforesaid code has not been suspended.

54

Eramet - Combined Shareholders' Meeting of 26 May 2020

7.2.3. Items of the remuneration paid or granted in respect of the 2019 financial year subject to the vote of the Shareholders' Meeting that will be held in 2020 in application of Article L. 225-100, III of the French Commercial Code.

Amounts granted in

Amounts paid

Remuneration

respect of 2019 or

in respect of

Presentation

items

accounting

2019

valuation

No suspended employment contract.

Christel Bories holds a corporate office.

Gross fixed remuneration, paid for the 2019

financial year in accordance with the provisions

Fixed

€800,000

€800,000

adopted by the Board of Directors of Eramet SA on

remuneration

23 February 2017.

It is identical to the fixed remuneration paid in

2018.

At its meetings of 19 February 2020 and 12 March

2020, the Board of Directors, on recommendation

by the Remuneration Committee and following

validation of the financial items by the Audit

Committee, approved the amount of variable

remuneration for Christel Bories for the financial

year 2019 at €736,000 (i.e., 92% her target variable

remuneration).

The variable portion is based on quantitative and

qualitative objectives, whose selection and

weighting are proposed by the Remuneration

Committee and approved by the Board of

Directors.

These objectives are based for 60% on safety and

working conditions and on quantitative economic

736,000 euros

€566,160

performance objectives and for 40% on qualitative

(amount paid in

objectives:

Annual variable

(amount applied for

2019 in respect

Quantitative objectives (60%),

the achievement

remuneration

the 2019 financial

of financial year

rate of which is detailed in Section 7.2.1.1 a ii:

year)

2018)

• 10% on safety (accident frequency rate of

employees, temporary

workers and

subcontractors) which is reduced if a fatal

accident occurs.

• 25% on current operating income

• 25% on operating cash-flow

The objectives achieved (100%) correspond to the

budget figures.

Qualitative objectives (40%) detailed for 2019 in

section 7.2.1.1 a ii.

The target-based annual variable portion is set at

100% of gross annual fixed remuneration based on

the achievement rate of various goals. This

remuneration may vary from 0 to 150% of gross

annual fixed remuneration, 100% of fixed

remuneration corresponding to 100% of goals

achieved. It may not exceed 150% of gross annual

55

Eramet - Combined Shareholders' Meeting of 26 May 2020

fixed remuneration. The variable portion for goals

achieved and the maximum variable portion are

reviewed each year by the Remuneration

Committee in relation to market practice, as part of

remuneration surveys conducted annually.

The Company cannot demand that the annual

variable remuneration be returned.

Deferred variable

N/A

Christel Bories does not receive any deferred

remuneration

variable remuneration.

Multi-year

Christel Bories does not receive any multi-year

variable

N/A

variable remuneration.

remuneration

Exceptional

N/A

Christel Bories does not receive any exceptional

remuneration

remuneration.

The Board of Directors of 20 February 2019

confirmed, in accordance with the authorisation of

the Shareholders' Meeting of 24 May 2018 (11th

resolution), that Christel Bories would be granted

15,000 performance shares when all the

performance conditions are exceeded, which

represents a share grant of 10,000 shares per target

when the performance conditions of the plan are

fully achieved, for an estimated value of €785,550

(i.e., 0.06% of the share capital) according to the

method adopted for the consolidated financial

statements (fair value of the share on the day of the

15,000 bonus shares

share grant by the Board of Directors). This

= €785,550

number corresponds to the number of shares that

(applying the method

may be vested, fully or partially, three years after

used in the

they are granted provided that the performance

Performance

consolidated

conditions are fully or partially met. Furthermore,

shares

or

stock

financial statements,

these performance shares are subject to an

options,

or

any

fair value of the

additional two-year holding period and 20% of

other long-term

share on the day of

these shares are prohibited from sale until the end

remuneration

granting by the

of the corporate officer's term of office.

item

Board of Directors)

These very rigorous performance conditions are

Options = N/A

calculated over a three-year period, as follows:

- the relative performance of Eramet shares

Other items = N/A

for one-third of the share grant (this

involves comparing the change in total

shareholder return over a three-year period

with that of a panel of around 37

comparable companies on the Euromoney

Global Mining Index; Diversified Metals

& Mining, Steel; this performance

condition being achieved at 150% if the

Eramet share is ranked among the top

15% of the panel); and

- the intrinsic performance of certain

financial indicators achieved in three

instalments over a three year period for

56

Eramet - Combined Shareholders' Meeting of 26 May 2020

two-thirds of the share grant (equal to one-

third of EBITDA and one-third of ROCE,

the annual objectives referring to the

Company's budgetary targets); this

performance condition is only met at

150% when the targets are significantly

out-performed.

Christel Bories was not granted any other long-

term remuneration item during the financial year

ended 31 December 2019.

Remuneration

Christel Bories does not receive remuneration for

for term of office

N/A

the offices she holds at Eramet and its subsidiaries.

as Director

Benefits of any

N/A

Christel Bories does not have a company car.

kind

Remuneration items falling due or granted for the financial year ended which have been or are subject to shareholder approval pursuant to the procedures related to regulated agreements and commitments

Amounts granted

Amounts paid in

Remuneration

in respect of 2019

respect of 2019

Presentation

items

or accounting

valuation

Compensation

No payment

In case of dismissal (except for gross misconduct)

related to

or forced resignation, particularly following a

taking up or

change of control of the company or substantial

leaving a post

imposed changes to the scope of responsibility,

Christel Bories will be awarded severance pay

equal to two years of her gross fixed and variable

remuneration. This benefit is subject to the

condition that the sum of gross variable

remuneration received over the last three complete

years of her term of office must be 35% or more of

the total gross annual fixed remuneration received

during the same three-year period. In the event that

the number of full years is less than three, the

performance will be assessed based on the actual

duration of the term of office, at the discretion of

the Board of Directors on the proposal from the

Remuneration Committee.

In accordance with the procedures related to

regulated agreements and commitments and to the

provisions of Article L.225-42-1 of the French

Commercial Code, this commitment was authorised

by the Board of Directors on 23 February 2017 and

approved by the General Shareholders' Meeting of

24 May 2018.

57

Eramet - Combined Shareholders' Meeting of 26 May 2020

Contribution

Christel Bories is covered by a life insurance policy

Article 82

under Article 82 of the French General Tax Code

scheme

On 26 July 2017, the Board of Directors, acting on

a proposal from the Remuneration Committee,

authorised the implementation of the system under

the following conditions:

The annual amount of the additional remuneration

paid is 30.39% of the total gross annual

remuneration (fixed + variable) paid to Christel

Bories during the reference year. The basis for

calculating this additional remuneration includes

not only fixed remuneration but also variable

remuneration.

The additional remuneration determined in

accordance with the preceding provisions shall give

rise to the following two payments:

The financing of a life insurance contract:

The Company has arranged for Christel Bories

to join a life insurance policy underwritten by

the Company with an approved insurance

company.

This contract, known as "Article 82", is an

individual life insurance contract.

The financing of this contract is fully covered

€466,790

€415,176

by the Company and represents 50% of the

additional

remuneration

determined

in

accordance with the above.

It does not constitute a retirement commitment.

An annual cash payment:

Each year, the company pays an amount in cash

equal to 50% of the additional remuneration

determined in accordance with the above

provisions, in order to cover the related social

and tax charges.

On behalf of the financial year 2019, the basis for

calculating this remuneration includes the fixed

remuneration and the variable remuneration and is

accordingly subject to performance conditions.

Considering the achievement rate of 2019 variable

remuneration objectives, which corresponds to

92%, the amount of employer contribution totals

€ 466,790 broken down into the proportions

mentioned above.

The company's commitment is limited to the

payment of the contribution mentioned above and it

remains free to terminate this contract at any time.

Supplementary

Employer share

Employer share

Christel Bories benefits from the supplementary

insurance

Healthcare costs

Healthcare costs

healthcare plan and the supplementary disability

scheme and

€1,227

€1,227

and life insurance scheme operating within the

healthcare plan

Eramet Group.

Employer share and

Employer share and

58

Eramet - Combined Shareholders' Meeting of 26 May 2020

life insurance:

life insurance:

In accordance with the procedures related to

€7,391

€7,391

regulated agreements and commitments, this

commitment was authorised by the Board of

Directors on 23 February 2017 and approved by the

General Shareholders' Meeting of 24 May 2018.

7.2.4. Presentation of the remunerations for executive corporate officers

Table 1 - Summary table of the remuneration, shares and options granted to the executive corporate officer

In euros

Remuneration

Value of shares

Total

granted in the

granted during the

financial year (1)

year (2)

2019

2018

2019

2018

2019

2018

Christel Bories

2 002 790

1 868 993

785 550

1 754 700

2 788 340

3 623 693

Chairman and CEO

Total Corporate Officers

2, 002, 790

1, 868, 993

785, 550

1, 754, 700

2, 788, 340

3, 623, 693

  1. The valuation method used to calculate the value of performance shares does not permit the actual remuneration of executives to be extrapolated from these figures for the years in question.
  2. Calculated according to the fair value per share on the day of granting by the Board of Directors, namely €52.37 at 20/02/2019, €116,98 at 22/03/2018 - no options were granted during the financial year. The valuation corresponds to the maximum grant of 15,000 shares, the target being 10,000 shares for a 100% achievement.

Valuation of the other remuneration plans: there is no:

  • long-termremuneration plan
  • stock options plan

Table 2- Summary of the remuneration of the executive corporate officer

Amounts

Amounts

For 2019

For 2018

Granted

Paid

Granted

Paid

Christel Bories

Chairman and CEO

Fixed remuneration

800 000

800 000

800 000

800 000

Annual variable remuneration

736 000

566 160

566 160

854 600

Contribution to the standard scheme

466 790

415 176

502 833

502 833

type Art. 82

Remuneration allocated for term of

0

0

0

0

office as Director

Benefits in kind

0

0

0

0

Total Corporate Officers

2 002 790

1 781 336

1 868 993

2 157 433

59

Eramet - Combined Shareholders' Meeting of 26 May 2020

No multi-year variable remuneration fell due or was paid out during the financial year.

The combined total remuneration received by the top five earners at Eramet in respect of 2019 was €4,318,444.28, which has been certified by the Statutory Auditors.

Table 3 - Remuneration received by non-executive corporate officers

Eramet

Other

Total

Total

companies

2019

2018

Michel ANTSELEVE

36 650

-

36 650

41 650

Christel BORIES (1)

-

-

-

-

Emeric BURIN des ROZIERS (3)

15 833

-

15 833

-

Christine COIGNARD

53 000

-

53 000

60 000

François CORBIN (3)

24 833

-

24 833

-

Cyrille DUVAL (SORAME)

51 500

33 000

84 500

79 000

Édouard DUVAL (2)

16 250

16250

50 000

Georges DUVAL (2)

14 167

-

14 167

42 500

Jérôme DUVAL (3)

26 933

-

26 933

-

Nathalie de La FOURNIERE (CEIR)

32 500

-

32 500

37 500

Frédéric GAIDOU (4)

30 000

-

30 000

6 666

Autres rémunérations hors mandat social : 88 459 €

Marie Axelle GAUTIER (5)

-

-

-

50 334

Jean Yves GILET

35 000

-

35 000

45 000

Philippe GOMES

31 100

-

31 100

35 125

Manoelle LEPOUTRE

47 917

-

47 917

47 500

Jean-Philippe LETELLIER (6)

30 000

-

30 000

15 000

Autres rémunérations hors mandat social : 94 581 €

Miriam MAES

68 500

-

68 500

69 000

Louis MAPOU (7)

18 050

-

18 050

13 883

Ferdinand POAOUTETA (8)

-

-

-

3 333

Pia OLDER (9)

-

-

-

22 500

60

Eramet - Combined Shareholders' Meeting of 26 May 2020

Catherine RONGE

30 000

-

30 000

35 000

Sonia SIKORAV

53 000

-

53 000

60 000

Claude TENDIL

52 500

-

52 500

60 000

Antoine TREUILLE (2)

31 217

-

31 217

90 825

Bruno VINCENT (10)

68 000

-

68 000

75 000

Total

766 950

33 000

799 950

939 816

(1) Other remuneration: see other tables related to executive corporate officers' remuneration.

  1. Term of office expired on 23 May 2019 (3) Appointed on 23 May 2019 (4) Director representing employees - Term of office begins on 12 November 2018 (5) Director representing employees - Designation on

12 November 2014 -Term of office expired on 11 November 2018 (6) Director representing employees - Term of office begins on 23 November 2018 (7) Appointed at the General Shareholders' Meeting of 24 May 2018

  1. Ferdinand Poaouteta's term of office ended up 4 May 2018 (9) Director representing employees - appointed 23 June 2014 - End of term of office 22 June 2018 (10) Amount paid to the Ministry of Finance - on 23 May 2019, Bruno Vincent is appointed State representative.

Tables 4 and 5- Not applicable

No share purchase or subscription options were granted to executive corporate officers during the financial year. No share purchase or subscription options were exercised by executive corporate officers during the financial year.

Table 6- Performance shares granted to each executive corporate officer during the year

Plan no.

Number

Value of

Acquisition

Date

of shares

Performance conditions

and date

shares (1)

date

available

granted

Relative performance of Eramet shares

(TSR) compared to that of companies

included in the indices (Euromoney

global mining index: diversified metals

C.

Plan from

15,000

785,550

20/02/2022

20/02/2024

& mining, steel) (1/3) and intrinsic

Bories

20/02/2019

performance of economic indicators

(1/3) EBITDA and (1/3) ROCE at

constant economic conditions of the

budget; progressive acquisition over 3

years

Total

15,000

  1. Award of 10,000 shares per target, when the performance conditions of the plan are fully met. Over-performance on all the performance conditions can lead to the award of a maximum of 15,000 shares. Calculated per target, according to the fair value of the share on the date of grant by the Board of Directors, namely € 52.37 on 20/02/2019.

Table 7-- Not applicable

No performance shares became available during the financial year for the executive corporate officer.

61

Eramet - Combined Shareholders' Meeting of 26 May 2020

Table 8-- Not applicable

There is no share purchase or subscription option plan currently in operation.

Table 9- Performance shares - Information

2013 plan

2014 plan

2015 plan

2016 plan

2017 plan

2018 plan

2019 plan

Date

of

Shareholders'

15/05/2012

15/05/2012

15/05/2012

27/05/2016

27/05/2016

27/05/2016

24/05/2018

Meeting

Date of Board

21/03/2013

20/02/2014

19/02/2015

27/05/2016

23/02/2017

22/03/2018

20/02/2019

Meeting

Total no. of

shares granted,

of which number

145 040

143 510

132 680

134 327

142 546

206 056 (1)

179 596 (1)

granted to (total)

(1)

including

the

corporate officer

C. Bories (1)

12 500

15 000

15 000

P. Buffet (until

22 405

22 405

22 405

22 405

0

0

0

23/05/2017)

G. Duval (until

5 085

5 085

3 000

0

0

0

0

22/04/2016)

P. Vecten (until

4 730

4 730

4 730

0

0

0

0

22/04/2016)

B. Madelin

3 970

3 970

3 970

0

0

0

0

E. Duval

900

900

0

0

0

0

0

C. Duval

500

500

0

0

00

0

0

Date of vesting of

France

Plan

21/03/2016

20/02/2017

19/02/2018

27/05/2019

23/02/2020

22/03/2021

20/02/2022

shares

End

date

of

holding

period

21/03/2018

20/02/2019

19/02/2020

27/05/2021

23/02/2022

22/03/2023

20/02/2024

France

End date of

vesting and

holding period

21/03/2017

20/02/2018

19/02/2019

27/05/2020

23/02/2021

22/03/2022

20/02/2023

for International

Plan shares

Performance

of

the

Total Shareholder return (TSR) of

Relative

performance

of

Eramet

share

price

in

Eramet shares compared to that of

Eramet

shares

(TSR)

relation

to

that

of

companies included in the indices

compared

to

that

of

comparable

companies

(Euromoney

global mining index:

companies included in the

Performance

listed

on

the

Stoxx

600

diversified metals & mining, steel) (1/3)

indices

(Euromoney

conditions

Basic

Resources index

and intrinsic performance of economic

global

mining

index:

(1/3)

and

intrinsic

indicators

(2/3) (current

operating

diversified

metals

&

performance

of

financial

income/CA and cash flow from

mining, steel) (1/3)

and

indicators (2/3) (operating

operating

activities;

progressive

intrinsic

performance

of

margin (current operating

acquisition over 3 years

economic

indicators (1/3)

62

Eramet - Combined Shareholders' Meeting of 26 May 2020

income / revenue) and

EBITDA and (1/3) ROCE

operating

cash flow);

at

constant

economic

progressive

acquisition

conditions of

the budget;

over 3 years

progressive

acquisition

over 3 years

Number

of

shares vested

at

31/12/2019

5 209

10 045

17877

(International

Plan)

Number

of

shares vested

at

18 165

34 626

59 939

85 660

31/12/2019

(France Plan)

Cumulative

number

of

121,666

98,839

54,864

21,542

cancelled

or

lapsed shares

Performance

shares remaining

0

0

0

27,125

at financial year

end

(1) number of shares at maximum performance

2013 plan

2014 plan

2015 plan

2016 plan

2017 plan

2018 plan

2019 plan

Vesting rate

of

16.37%

32.19%

49.44%

86.67%

55.60%

selective plans

For the 2013 and 2014 performance share plans, the performance conditions are calculated over a three- year period, as follows: the relative performance of Eramet shares for one-third of the share grant (this involves comparing the change in total shareholder return over a three-year period with that of a panel of around 30 comparable companies on the Stoxx 600 Basic Resources Index, with the performance conditions being fully achieved if the Eramet share is ranked among the top 15% of the panel) and the intrinsic performance of certain financial indicators achieved in three instalments over a three year period for two-thirds of the share grant (one-third of the current operating income and one-third of the operating cash-flow from operating activities, the annual objectives referring to the Company's budgetary targets, with performance conditions only being fully achieved when these targets are significantly out-performed). Taking into consideration the performance conditions, the vesting rate as a percentage of shares awarded is as follows: 2013: 16.37% - 2014: 32.19%.

For the 2015, 2016 and 2017 performance share plans, the performance conditions are calculated over a three-year period, as follows: the relative performance of Eramet shares for one-third of the share grant (this involves comparing the change in total shareholder return over a three-year period with that of a panel of around 50 comparable index companies (Euromoney Global Mining Index; Diversified Metals & Mining, Steel), with the performance conditions being fully achieved if the ERAMET share is ranked among the top 15% of the panel) and the intrinsic performance of certain financial indicators achieved in three instalments over a three year period for two-thirds of the share grant (one-third of the current operating income and one-third of the operating cash-flow from operating activities, the annual objectives referring to the Company's budgetary targets, with performance conditions only being fully achieved when these targets are significantly out-performed). Taking into consideration the performance conditions, the vesting rate as a percentage of shares awarded is as follows: 2015: 49.44% - 2016 86.67% - 2017: 58.00%

63

Eramet - Combined Shareholders' Meeting of 26 May 2020

The very rigorous performance conditions for the 2018 and 2019 plans are calculated over a three-year period, as follows: the relative performance of Eramet shares for a third of the share grant (this entails comparing the change in total shareholder return over a three-year period with that of a panel of around 37 comparable companies on the Euromoney Global Mining Index ; Diversified Metals & Mining, Steel; this performance condition is only met at 150% if the share is ranked among the top 15% of the panel) and the intrinsic performance of certain financial indicators achieved in three instalments over a three-year period for two thirds of the share grant (for one-third Earning before interest, taxes, depreciation and amortization (EBITDA) at constant economic conditions of the budget and for one-third of Return On Capital Employed (ROCE), the annual objectives referring to the Company's budgetary targets); this performance condition is met at 150% only when these targets are significantly out-performed.

Table 10- Not applicable

There is no multi-year remuneration for the executive corporate officer

Table 11 - Summary by corporate officer

Compensation or

benefits falling

Employment

Supplementary

due or which may

Compensation

Corporate officers

fall due, as the

related to a non-

contract

pension plan

result of

compete clause

departure or a

change of position

Christel Bories

Chairman and

CEO:

No, but the

23/05/2017

No

Company is

Yes

No

End of term of office for

financing a life

the Director at the General

insurance contract

Shareholders'

Meeting

called to approve the 2020

financial statements

64

Eramet - Combined Shareholders' Meeting of 26 May 2020

HOW TO ATTEND OR VOTE AT THE SHAREHOLDERS' MEETING?

I. Prior formalities to participate in the General Shareholders' Meeting

All shareholders, regardless of the number of shares they own, have the right to participate in the Meeting, either by personally attending, either by being represented, or by voting at distance (by internet or by postal vote using a distance voting form), under the terms and conditions set forth by the law and regulations in force.

All shareholders may be represented at the Meeting by another shareholder, by their husband/spouse, or by a partner with whom they have entered into a Civil Solidarity Pact or any other individual or legal entity of their choice under the conditions provided for in Article L. 225-106 of the French Commercial Code.

Warning:

In respect of the current context related to Covid-19 and as a precautionary measure, shareholders are invited to favour remote participation ahead of the General Assembly as provided by regulations (i.e. voting by mail or internet via the vote ACCESS website or giving power to the Chairperson).

In addition, the modalities of physical participation to the General Assembly could change according to health and/or legal requirements.

You are invited to refer to the section dedicated to the General Assembly on the company's website: https://www.eramet.com

In any case, no cocktail or gift giveaway will be organized for shareholders showing up on site.

A notice of meeting containing a single remote or proxy voting form or application for an admission card will be sent automatically to all registered shareholders. The bearer shareholders will have to contact their financial intermediary from which their shares are registered in order to obtain the remote or proxy voting form or application for an admission card. Applications for submissions of forms, to be issued in due time, must be made at least 6 days before the date of the Assembly, that is to say on May 20, 2020 at the latest.

In accordance with Article R. 225-85 of the French Commercial Code, the exercise of the voting right, whatever the mode chosen, requires that each shareholder justifies of this latter quality through the registration of his/her shares held in the accounts two working days preceding the Meeting, that is to say on May 22, 2020 by 00:00 hours (midnight), Paris time:

  • either in the registered share accounts held by BNP Paribas Securities Services for the company, for shareholders owning registered shares;
  • or in bearer share accounts held by the authorized intermediary mentioned in article L. 211-3 of the French Monetary and Financial Code, for shareholders owning bearer shares.

The registration or the accounting registration of the securities in the bearer share accounts held by an authorized intermediary referred to in Article L. 211-3 of the French Monetary and Financial Code must be evidenced by a certificate of participation issued by the latter, attached to the remote voting form, proxy voting form, or to the application for admittance card, issued in the name of the shareholder or on behalf of the shareholder, in the name of the registered intermediary representing him/her.

In accordance with Article R. 225-85 of the French Commercial Code, shareholders who have voted remotely, sent a proxy or requested for an admittance card or a certificate of participation may no longer choose another method of participation in the Assembly, but may nevertheless give up all or part of its actions.

65

Eramet - Combined Shareholders' Meeting of 26 May 2020

  1. Methods of participation in the General Shareholders' Meeting

2.1 Participation in the General Shareholders' Meeting

  • Postal or electronic application for an admittance card
  • Registered shareholders who wish to attend the General Shareholders' Meeting should apply either for an admittance card by using the sole proxy/voting forms attached to the notice or online on the secure VOTACCESS platform which is accessed via the Planetshares website at the following web address: https://planetshares.bnpparibas.com.

Holders of shares in "pure registered" form should log in to the Planetshares website using their usual access code.

Holders of administered registered shares should log on to the Planetshares website using their identifier number which can be found at the top right-hand side of their paper voting form. If a shareholder is unable to locate their identifier and/or their password, he/she should telephone +(33) 1 55 77 65 00 for assistance.

Having logged in, shareholders holding registered shares should follow the instructions appearing on the screen to access the VOTACCESS website and request for an admittance card.

The holders of "bearer shares" wishing to attend the General Assembly must ask their authorized intermediary for a certificate of participation if they wish to obtain an admittance card by post. The latter will then be responsible for forwarding this certificate to BNP Paribas Securities Services, CTO Assemblies, Grands Moulins de Pantin, 9, rue du Débarcadère, 93761 Pantin Cedex, who will send them their admittance card. If the shareholders wish to apply for their admittance card electronically, it is of their responsibility to inquire as to whether their account-keeping institution is connected to the VOTACCESS site or not, and, if so, whether this access is subject to special conditions of use.

If the shareholders' account-keeping institution is connected to the VOTACCESS website, the shareholders should log in to the web portal of their account-keeping institutions using their usual access codes. They should then click on the icon which appears on the line corresponding to their Eramet shares and follow the instructions appearing on the screen to access the VOTACCESS website and apply for an admittance card.

In the event that he shareholders have not received their admission cards on the second business day preceding the Meeting (i.e. May 22, 2020) at midnight, Paris time, they may ask their authorized intermediary holding their securities account to issue them a certificate of participation justifying of their shareholder quality and to be admitted to attend the Shareholders' Meeting.

  • Postal distance or proxy voting

Shareholders not attending the General Shareholders' Meeting who wish to vote remotely or give power to the Chairperson or to the persons listed in the provisions of Article L. 225-106 of the aforementioned Code of Commerce, must use the single form of proxy / distance voting form attached to the notice of meeting and send it to BNP Paribas Securities Services, CTO Assemblies, Grands Moulins de Pantin, 9, rue du Débarcadère, 93761 Pantin Cedex or transmit voting instructions on the VOTACCESS website.

In the case of bearer shareholders, the form will be accompanied by the certificate of participation issued by the authorized intermediary.

To be taken into account, the duly completed and signed combined distance/proxy voting forms must be sent back to BNP Paribas Securities Services at least three calendar days before the date of the Meeting (i.e. May, 23 2020).

  • Electronic distance or proxy voting

The VOTACCESS website will be open from May 6, 2020 until May 25, 2020 at 3 pm (the day before the meeting).

66

Eramet - Combined Shareholders' Meeting of 26 May 2020

  • Holders of "pure or administered registered shares" who wish to vote on the Internet will access the VOTACCESS website via the Planetshares website whose address is as follows: https://planetshares.bnpparibas.com under the conditions below.

Holders of pure registered shares will have to connect to the Planetshares site with their usual access codes.

Holders of "administered registered shares" will need to log in to the Planetshares site using their ID number located at the top right of their paper voting form. In case the shareholder is no longer in possession of his username and / or password, he can contact the following number +33-1 55 77 65 00 put at his/her disposal.

After having logged on, registered shareholders should follow the instructions appearing on the screen to access the VOTACCESS website and to vote or to designate or withdraw a proxy at the latest by the eve of the General Shareholders' Meeting at 3:00 pm (Paris time).

However, in order to avoid any congestion of the VOTACCESS website, shareholders are advised not to wait until the day before the General Assembly to vote.

  • For employees holding registered free shares:

Employees holding free shares who wish to vote by internet should apply on line on the secure VOTACCESS platform which is accessed via the Planetshares - My Proxy website at the following web address: https:// planetshares.bnpparibas.com

Employees holding free shares will have to use the identification number which can be found at the top right-hand side of their paper voting form and the identification number corresponding to the last 8 digits of their identifier number previously attributed by Société Générale Securities Services (made up of 16 digits which can be found at the top left-hand side of the account statement issued by Société Générale Securities Services - this account number will not be stored, used or otherwise circulated by BNP Paribas Securities Services).

After having logged in, the employee shareholder will have to follow the instructions given on the screen in order to access the VOTACCESS site and vote, or appoint or revoke an agent, no later than the day before the Assembly, at 3:00 p.m (Paris time).

However, in order to avoid any congestion of the VOTACCESS website, shareholders are advised not to wait until the day before the General Assembly to vote.

  • Bearer shareholders will need to inquire as to whether or not their account-keeping institution is connected to the VOTACCESS site and, if so, whether this access is subject to specific terms of use.

If the shareholders' account-keeping institution is connected to the VOTACCESS website, the shareholders should log in to the web portal of their account-keeping institution using his/her usual access codes. He/she should then click on the icon which appears on the line corresponding to his/her Eramet shares and follow the instructions appearing on the screen to access the VOTACCESS website to vote or to designate or withdraw a proxy.

If the shareholder's account-keeping institution is not connected with the VOTACCESS website, the shareholder may designate or withdraw a proxy by forwarding notice electronically, in accordance with the provisions of article R. 225-79 of the French Commercial Code, as follows:

  • the shareholder should send an e-mail to: paris.bp2s.france.cts.mandats@bnpparibas.com. That e-mail
    must contain the following information: name of the Company concerned, date of the General Shareholders' Meeting, surname, first name, address and bank account details of the shareholder concerned, in addition to the surname, first name and, if possible, address of the proxy;

67

Eramet - Combined Shareholders' Meeting of 26 May 2020

  • the shareholder will also have to ask, as a mandatory requirement, to the financial intermediary in charge of managing his/her securities account to send written confirmation to the General Shareholders' Meetings Department of BNP Paribas Securities Services - CTO Assemblies - Les Grands Moulins de Pantin 9, rue du Débarcadère - 93761 Pantin Cedex.

Please note that the sole notifications of proxies' appointment or revocation should be sent to the abovementioned e-mail address, any other request or notification relating to another object will not be able to be taken into account and / or dealt with.

In order appointments' designations and revocation of proxies notified electronically may be taken into account, the mandatory confirmations must be received no later than the day before the General

Shareholders' Meeting at 3:00 p.m (Paris time).

  • Written questions :

In accordance with the provisions of Article R. 225-84 of the French Commercial Code, any shareholder wishing to submit written questions must send them to the Chairman of the Board of Directors at the Company's registered office (Eramet - Group Legal Department - Jean de L 'Hermite - 10 boulevard de Grenelle - 75015 Paris) by registered letter with acknowledgment of receipt, or by electronic communication (e-mail:assemblee-generale@eramet.com), at later on the fourth working day preceding the Assembly (that is to say on May 19, 2020).

These questions, to be taken into account must imperatively be accompanied by a certificate of registration issued by the authorized intermediary holding their account.

In accordance with the legislation in force, a written question will be deemed to have been answered back as soon as it appears on the Company's website in a section devoted to questions and answers.

  • Shareholders' right of communication :

All documents and information relating to this Shareholders' Meeting will be made available to the shareholders in accordance with the legal and regulatory conditions in force and in particular any information referred to in Article R. 225-73-1 of the French Commercial Code, will be published on the Eramet Website https://www.eramet.comno later than the twenty-firstday preceding the General Shareholders' Meeting at the latest, that is on May, 5 2020).

The Board of Directors

68

Eramet - Combined Shareholders' Meeting of 26 May 2020

REQUEST FORM FOR DOCUMENTS

AND INFORMATION

(Non compulsory - Pursuant to article R 225-83 of the French Commercial Code)

The documents are available and downloadable on the Eramet website: www.eramet.com

To be sent to

BNP PARIBAS Securities Services

CTO Assemblées

Les Grands Moulins de Pantin - 9 rue du Débarcadère

93761 Pantin Cedex

I the undersigned,

Name and first name ………………………………………………………….

Or Company name…………………………………………………………….

Address……………………………………………………………………….

Or registered office address

Email address: I__I__I__I__I__I__I__I__I__I__I__I__I__I__I__I__I__I__I__I @ I__I__I__I__I__I__I__I__I__I__I__I__I__I__I__I__I

In my capacity of shareholder of Eramet, a French limited liability company "Société Anonyme", having its registered office 10 boulevard de Grenelle - 75015 Paris,

Hereby acknowledge having received the documents relating to the Combined Ordinary and Extraordinary General Shareholders' meeting to be held on 26 May 2020, pursuant to article R. 225-81 of the French Commercial Code, namely: the agenda, draft resolutions and explanations on resolutions, summary of operations for the previous financial year, the vote-by-post/vote by proxy form and this request form for documents.

Request that the company sends me a free copy of the documents 83 of the French Commercial Code, before the General Meeting of

and information listed in article R. 225- 26 May2020.

Paper format of the documents

Digital format of the documents

Date :

Signature :

Pursuant to article R 225-88 of the French Commercial Code, owners of registered shares may obtain copies of the documents and information covered by articles R 225-81 and R 225-83 of the French Commercial Code for each subsequent General Meeting by a single request (Article R 225-83 includes notably, according to the agenda of the meeting, information on directors and officers, new candidates as the case may be, the management report, the balance sheet and profit and loss statement, notes to the accounts, the special report of statutory auditors and other reports by the auditors as provided by Law). Should shareholders wish to use this option, this should be indicated on this form.

69

Eramet - Combined Shareholders' Meeting of 26 May 2020

Eramet

A Public Limited Company with a share capital of 81,239,800 Euros

Registered Head Office : 10 boulevard de Grenelle 75015 Paris

632 045 381 RCS Paris

Website : www.eramet.com

70

Attachments

Disclaimer

Eramet SA published this content on 05 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 May 2020 15:58:03 UTC